US6561998B1 - Transluminal devices, systems and methods for enlarging interstitial penetration tracts - Google Patents

Transluminal devices, systems and methods for enlarging interstitial penetration tracts Download PDF

Info

Publication number
US6561998B1
US6561998B1 US09/056,589 US5658998A US6561998B1 US 6561998 B1 US6561998 B1 US 6561998B1 US 5658998 A US5658998 A US 5658998A US 6561998 B1 US6561998 B1 US 6561998B1
Authority
US
United States
Prior art keywords
tissue
tract
debulker
enlarging
distal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/056,589
Inventor
Alex T. Roth
J. Christopher Flaherty
Adrian E. Johnson
Joshua Makower
Jason Brian Whitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Vascular Inc
Original Assignee
Transvascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transvascular Inc filed Critical Transvascular Inc
Priority to US09/056,589 priority Critical patent/US6561998B1/en
Assigned to TRANSVASCULAR, INC. reassignment TRANSVASCULAR, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ROTH, ALEX T., JOHNSON, ADRIAN E., FLAHERTY, J. CHRISTOPHER, WHITT, JASON BRIAN, MAKOWER, JOSHUA
Priority to EP99916412A priority patent/EP1069869A4/en
Priority to PCT/US1999/007518 priority patent/WO1999051162A1/en
Priority to JP2000541938A priority patent/JP2002510522A/en
Priority to IL13872499A priority patent/IL138724A0/en
Priority to AU34737/99A priority patent/AU763400B2/en
Priority to CA002326769A priority patent/CA2326769A1/en
Priority to US10/346,556 priority patent/US20030181938A1/en
Publication of US6561998B1 publication Critical patent/US6561998B1/en
Application granted granted Critical
Assigned to MEDTRONIC VASCULAR, INC. reassignment MEDTRONIC VASCULAR, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TRANSVASCULAR, INC.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/320016Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
    • A61B17/32002Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes with continuously rotating, oscillating or reciprocating cutting instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • A61B17/32075Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • A61B18/245Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter for removing obstructions in blood vessels or calculi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/104Balloon catheters used for angioplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1482Probes or electrodes therefor having a long rigid shaft for accessing the inner body transcutaneously in minimal invasive surgery, e.g. laparoscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22065Functions of balloons
    • A61B2017/22069Immobilising; Stabilising
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255Optical elements at the distal end of probe tips
    • A61B2018/2266Optical elements at the distal end of probe tips with a lens, e.g. ball tipped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255Optical elements at the distal end of probe tips
    • A61B2018/2272Optical elements at the distal end of probe tips with reflective or refractive surfaces for deflecting the beam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/03Automatic limiting or abutting means, e.g. for safety
    • A61B2090/033Abutting means, stops, e.g. abutting on tissue or skin
    • A61B2090/036Abutting means, stops, e.g. abutting on tissue or skin abutting on tissue or skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/064Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
    • A61B2090/065Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension for measuring contact or contact pressure

Definitions

  • the present invention relates generally to medical devices and methods, and more specifically to transluminal devices, systems and methods which are useable to enlarge interstitial tracts (e.g., man made puncture tracts or small passageways) which extend between two (2) anatomical conduits (e.g., blood vessels) or otherwise through tissue(s) within a mammalian body.
  • interstitial tracts e.g., man made puncture tracts or small passageways
  • anatomical conduits e.g., blood vessels
  • passageway-forming catheters are advanced into anatomical conduits (e.g., blood vessels) and are used to create one or more interstitial passageways which extend outwardly, from the conduit in which the catheter is positioned, to another conduit or anatomical structure.
  • Some of these procedures may be used to form flow-through passageways between the anatomical conduit (e.g., blood vessel) in which the passageway-forming catheter is positioned, and another anatomical conduit (e.g., another blood vessel) or a different location on the same anatomical conduit (e.g., a downstream site on the same blood vessel).
  • these procedures may be used to form access passageways between the anatomical conduit (e.g., blood vessel, urethra, fallopian tube, etc.) and another anatomical structure (e.g., a tumor, organ, muscle, nerve, etc.).
  • anatomical conduit e.g., blood vessel, urethra, fallopian tube, etc.
  • another anatomical structure e.g., a tumor, organ, muscle, nerve, etc.
  • the interstitial passageway(s) are initially formed by advancing a tissue-penetrating element (e.g., a small diameter needle or a flow of tissue-penetrating energy) from the passageway-forming catheter, through the wall of the anatomical conduit in which the catheter is positioned, and into the target location.
  • a tissue-penetrating element e.g., a small diameter needle or a flow of tissue-penetrating energy
  • the interstitial passageway which is formed by the initial passage of the tissue-penetration element from the passageway-forming catheter is of relatively small diameter-and must subsequently be enlarged (e.g., debulked, dilated, expanded, stretched) to accommodate the desired flow of biological fluid (e.g., blood) or passage of other substances/devices therethrough.
  • biological fluid e.g., blood
  • such enlargement of the initially formed interstitial passageway may be particularly important when the procedure is being performed to by-pass an obstruction within a coronary artery.
  • a primary interstitial passageway is formed between an obstructed coronary artery and an adjacent coronary vein, such that blood will flow from the obstructed artery into the adjacent coronary vein.
  • the arterial blood which enters the adjacent coronary vein through the primary interstitial passageway is allowed to retroperfuse the ischemic myocardium by retrograde flow through the coronary vein.
  • one or more secondary interstitial passageways are formed between the coronary vein into which the arterial blood has flowed and the obstructed artery (or some other coronary artery) to allow arterial blood which has entered the coronary vein to reenter the obstructed artery (or some other coronary artery), after having bypassed the arterial obstruction.
  • the primary and/or secondary interstitial passageway(s) remain patent and sufficiently large in diameter to support the continued flow of arterial blood to the myocardium.
  • the task of enlarging the small diameter interstitial passageway(s) (e.g., puncture tracts) formed by the initial passage of the tissue-penetrating element presents numerous technical challenges.
  • the prior art has included a number of catheter-based devices which may be used to enlarge or remove obstructive matter from the lumen of a blood vessel or other anatomical conduit (e.g., a blood vessel). These devices include; atherectomy catheters, embolectomy catheters, balloon angioplasty catheters, laser ablation catheters, etc.
  • these prior art lumen-enlarging/lumen-clearing devices have typically not been intended for use in small diameter puncture tracts which diverge at an angle from the conduit lumen in which the catheter is located, as is typically the case in applicant's above-summarized interventional procedures.
  • interstitial penetration tracts e.g., man-made punctures or small passageways
  • anatomical conduits e.g., blood vessels
  • the present invention provides devices which are useable in combination with each other (i.e., as a system) to enlarge an interstitial tract (e.g., a small diameter penetration tract through tissue) which extends from a blood vessel or other anatomical conduit of the body.
  • the tract enlarging systems of the present invention generally fall into three (3) major classifications—1) debulking-type systems, 2) dilating-type systems, 3) slicing-type systems and 4) two-catheter systems.
  • one debulking-type tract enlargement system (referred to herein as an “advanceable” debulker) generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough; b) a counter-traction member which is advanceable, i.) through the lumen of the tubular sheath and ii.) at least partially through the interstitial tract, such that the countertraction member engages or becomes positioned in relation to tissue which lies adjacent the interstitial tract to thereafter exert proximally-directed force upon such tissue; and, c) a debulker'(e.g., a tissue removing apparatus or flow of energy) which is advanceable out of the lumen of the sheath in a distal direction (i.e., substantially opposite the proximally-directed force being exerted by the counter-traction
  • another debulking-type tract enlargement system (referred to herein as a “retractable” debulker) generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough, and b) a pull-back debulker (e.g., a tissue-removing apparatus or flow of energy) which is i.) initially advanceable out of the lumen of the sheath in a distal direction so as to pass through the penetration tract which is to be enlarged, and ii.) thereafter retractable in the proximal direction so as to remove, tissue which lies adjacent the interstitial tract, thereby enlarging the interstitial tract.
  • a pull-back debulker e.g., a tissue-removing apparatus or flow of energy
  • a dilating-type tract enlargement system (referred to herein as a “dilating” system) which generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough, and b) a dilator (e.g., an elongate member) having at least one tissue-dilating member (e.g., a tapered, frusto-conical member, balloon or radial deployable member(s)) formed thereon, such dilator being advanceable into the penetration tract which is to be enlarged, and is subsequently useable to dilate such penetration tract, thereby resulting in the desired enlargement thereof.
  • tissue-dilating member e.g., a tapered, frusto-conical member, balloon or radial deployable member(s)
  • a positioning surface may be formed on the dilator to abut against tissue which lies adjacent the passageway in a manner which will enable the operator to determine that the dilator has been advanced to its desired position and is properly located to allow the dilate the interstitial tract as desired.
  • tissue-slicing system which generally comprises a) an elongate shaft which is advanceable through the interstitial tract, and b) at least one tissue slicing member which extends or is extendable from the shaft to incise or cut tissue which lies adjacent the interstitial tract as the shaft is advanced and/or retracted through the tract.
  • the tissue slicing member(s) may be initially disposed in a radially compact configuration which is flush with, or only slightly protrusive beyond, the outer surface of the shaft, thereby allowing the shaft to be advanced through the interstitial tract without cutting or disrupting the surrounding tissue. Thereafter, the tissue slicing member(s) is/are shifted to a radially expanded configuration wherein such tissue-slicing member(s) extend or protrude laterally from the shaft so as to slice, incise or cut at least some of the tissue which surrounds the tract.
  • the tissue-slicing member(s) need not be concentric about the shaft, but rather may be of substantially flat configuration so as to create a defined incision or cut in the tissue.
  • tissue-slicing member(s) may be configured so as not to completely sever and remove tissue in the manner of the above-summarized debulking-type embodiment, but rather may simply form a lit or incision adjacent the tract such that the surrounding tissue will continuously or intermittently separate to allow flow of fluid (e.g., blood) therethrough.
  • fluid e.g., blood
  • two-catheter type tract enlarging system (referred to herein as a “two-catheter” system) which is specifically useable to enlarge an interstitial tract or passageway which has been formed between two adjacent anatomical conduits (e.g., blood vessels).
  • Such two-catheter system generally comprises a) a first catheter having a tract-enlarging apparatus (e.g., a debulker, dialtor or tissue-slicing member of the above-described nature) which is advanceable from an opening at or near the distal end of that catheter, and b) a second catheter which has an anvil member (e.g., an abuttable surface or receiving cavity) which is sized and configured to correspond with the leading end of the tract-enlarging apparatus of the first catheter.
  • the first catheter is positioned in one of the anatomical conduits
  • the second catheter is positioned in the other anatomical conduit, with its anvil member located next to the interstitial tract or passageway which is to be enlarged.
  • the tract enlarging, apparatus is advanced through the tract or passageway until it registers with (e.g., abuts against or is received with) the anvil member of the second catheter.
  • the anvil member serves to provide counterforce against the tissue adjacent the initially formed tract or passageway so as to prevent unwanted protrusion or “tenting” of the tissue into the second anatomical conduit, and to ensure efficient cutting of the tissue in cases where a debulking or tissue slicing type tract enlarging apparatus is used.
  • either the debulking-type, dilating type, tissue-slicing type or two catheter type tract enlargement systems of the present invention may incorporate a guidewire lumen which extends longitudinally through the i.) tract enlarging member (e.g., debulker, dilator or tissue slicing member) to permit the tract enlarging member to be advanced over a small guidewire which has previously been passed through the penetration tract which is to be enlarged.
  • the provision of such guidewire lumen may permit the system to be used to dilate penetration tracts which are of extremely small diameter, or which have become substantially closed off due to constriction of the surrounding tissue, provided that a guidewire was previously inserted through such penetration tract.
  • energy such as radio-frequency energy or electrical resistance heat may be applied to the tract enlarging member (e.g., debulker, dilator, or tissue slicing member) to enhance the tract-enlarging efficiency thereof.
  • the tract enlarging member e.g., debulker, dilator, or tissue slicing member
  • FIG. 1 is a perspective view of a debulking-type tract enlarging system of the present invention.
  • FIG. 2 is a schematic perspective view of a human body having the tract enlarging system of FIG. 1 operatively inserted into the coronary vasculature.
  • FIG. 2 a is an enlarged, cut-away view of segment 2 a — 2 a of FIG. 2 .
  • FIG. 3 is an enlarged sectional view through line 3 — 3 of FIG. 2 a.
  • FIGS. 3 a - 3 d are step-wise showings of a presently preferred method for using the tract enlarging system of FIG. 1 to debulk and enlarge an interstitial penetration tract which has been created between a coronary artery and an adjacent coronary vein.
  • FIG. 4 is an enlarged, side elevational view of the distal portion of the tract enlarging system of FIG. 1 .
  • FIG. 4 a is a cross sectional view through line 4 a — 4 a of FIG. 4 .
  • FIG. 4 b is a cross sectional view through line 4 b — 4 b of FIG. 4 .
  • FIG. 4 c is a cross sectional view through line 4 c — 4 c of FIG. 4 .
  • FIG. 5 a is a side elevational view of the distal portion of the tract enlarging system of FIG. 1 disposed in a retracted configuration.
  • FIG. 5 b is a side elevational view of the distal portion of the tract enlarging system of FIG. 1 disposed in a retracted configuration.
  • FIG. 6 is a is a longitudinal sectional view of the distal portion of the subselective sheath component of the system of FIG. 1 .
  • FIG. 7 is a is a longitudinal sectional view of the distal portion of the tissue cutter component of the system of FIG. 1 .
  • FIG. 7 a is an exploded, longitudinal sectional view of the distal potion of the tissue cutter of FIG. 7 .
  • FIG. 8 is a side elevational view of the counter-traction member component of the system of FIG. 1 .
  • FIG. 8 a is an exploded, longitudinal sectional view of the distal potion of the counter-traction member of FIG. 8 .
  • FIG. 9 a shows a first alternative counter-traction member having a tissue-engaging member formed of radially expandable members, wherein the radially expandable members are in their collapsed configuration.
  • FIG. 9 b shows the first alternative counter-traction member of FIG. 9 a , with its radially expandable members in a partially expanded configuration.
  • FIG. 9 c shows the first alternative counter-traction member of FIG. 9 a , with its radially expandable members in their fully expanded configuration.
  • FIG. 10 a is a side elevational view of a debulking-type tract enlarging system which is equipped with a first type of an energy emitting debulker (e.g., a radio-frequency system).
  • a first type of an energy emitting debulker e.g., a radio-frequency system
  • FIG. 10 b is an enlarged perspective view in the distal end of the energy emitting debulker of FIG. 10 .
  • FIG. 10 c is a cross sectional view through line 10 c — 10 c of FIG. 10 a.
  • FIG. 10 d is a side elevational view of the distal portion of an another alternative debulking-type system which comprises an energy-emitting debulker in conjunction with an energy emitting counter-traction member, and wherein the energy emitting counter-traction member is in a retracted position.
  • FIG. 10 e shows the system of FIG. 10 c with its energy-emitting countertraction member in its extended position.
  • FIG. 10 f is a cross sectional view through line 10 e — 10 e of FIG. 10 d.
  • FIG. 10 g is a partial side elevational view of another energy-emitting debulker which incorporates an annular array of laser-transmitting optical fibers.
  • FIG. 10 g ′ is a cross-sectional view through line 10 g ′— 10 g ′ of FIG. 10 g.
  • FIG. 10 h is a partial side elevational view of another energy-emitting debulker having central laser-transmitting optical fiber (or fiber bundle) in combination with a frusto-conical prism which projects a generally conical pattern of laser light from the distal end of the device.
  • FIG. 10 h ′ is a cross-sectional view through line 10 h ′— 10 h ′ of FIG. 10 h.
  • FIG. 10 i is a partial side elevational view of another energy-emitting debulker having a rotatable laser-transmitting optical fiber (or fiber bundle) and a frusto-conical prism which projects a single ray of laser light but which, when rotated, will form a generally conical laser light pattern.
  • FIG. 10 i ′ is a cross-sectional view through line 10 i ′— 10 i ′ of FIG. 10 i.
  • FIG. 11 a shows a debulking-type tract enlarging system having a second alternative counter-traction member which comprises an inflatable tissue-engaging balloon, wherein the balloon is in its non-inflated, collapsed configuration.
  • FIG. 11 b is a cross sectional view through line 11 b — 11 b of FIG. 11 a.
  • FIG. 11 c shows the second alternative counter-traction member of FIG. 11 a , with its balloon in a fully inflated, expanded configuration.
  • FIG. 11 d shows the second alternative countertraction member of FIG. 11 a , with its balloon in its fully inflated, expanded configuration and the shaft fully retracted into the lumen of the debulker.
  • FIG. 11 e shows a debulking-type tract enlarging system having an advanceable debulker and a third alternative counter-traction member comprising splayable tissue-engaging members, wherein the tissue-engaging members are in there radially collapsed, non-splayed configuration.
  • FIG. 11 f shows the system of FIG. 11 e with its tissue-engaging members in their splayed, radially expanded configuration.
  • FIG. 11 g shows the system of FIG. 11 f with its counter-traction member is fully advanced out of the debulker.
  • FIG. 11 h shows the system of FIG. 11 g wherein the tissue-engaging members are in their radially expanded configuration and the counter-traction member has been fully retracted such that the distal end of the debulker engages the interior of the expanded tissue-engaging members.
  • FIG. 12 a is a side elevational view of the distal portion of a retractable debulking-type tract enlarging system of the present invention, wherein the retractable debulker is disposed in a distally extended position.
  • FIG. 12 b is a view of the system of FIG. 12A, wherein the debulker is disposed in a partially retracted position.
  • FIG. 13 is a side elevational view of a dilation-type tract enlarging system of the present invention, disposed with its dilator (i.e. balloon) in a stowed (i.e., deflated) position.
  • dilator i.e. balloon
  • stowed i.e., deflated
  • FIG. 13 a is view of the system of FIG. 13, disposed with its dilator (i.e., balloon) in an operative (i.e., inflated) position.
  • dilator i.e., balloon
  • FIG. 13 b is a cross sectional view through line 13 b — 13 b of FIG. 13 .
  • FIG. 13 c is a cross sectional view through line 13 c — 13 c of FIG. 13 .
  • FIG. 14 is a graphic illustration of a continuous emission of radiofrequency energy in accordance with the present invention.
  • FIG. 15 is a graphic illustration of intermittant or pulsed emission of radiofrequency energy in accordance with the present invention.
  • FIG. 16 is a longitudinal sectional view of the distal portion of a debulker of the present invention which incorporates an apparatus for controlling the pressure applied by the debulker and/or for signifying when the debulking procedure is complete.
  • FIG. 17 is a side elevational view of the distal portion of a tissue-cutting type of tract enlarging system of the present invention.
  • FIG. 18 a is a side elevational view of an alternative tissue-cutting tip for the system of FIG. 17 .
  • FIG. 18 b is a top plan view of the alternative tissue-cutting tip of FIG. 18 a.
  • FIG. 18 c is a distal end view of the alternative tissue cutting tip of FIG. 18 a.
  • FIG. 19 is a schematic showing of two adjacent blood vessels having a penetration tract formed therebetween, and a two-catheter tract enlarging system of the present invention operatively disposed therein to enlarge the penetration tract.
  • debulking-type tract enlarging systems 10 and 10 a include debulking-type tract enlarging systems 10 and 10 a , dilating-type tract enlargement systems 10 b , and tissue-slicing-type tract enlarging systems 10 c.
  • the debulking-type systems 10 , 10 a serve to remove (e.g., cut, sever, ablate, vaporize, etc.) tissue which surrounds or lies adjacent to the initially formed interstitial tract thereby enlarging the tract.
  • the description set forth in the following paragraphs includes a distally advanceable debulking-type system 10 as well as a proximally retractable debulking-type system 10 a.
  • FIGS. 1-9 show a preferred, distally-advanceable debulking-type tract enlarging system 10 which is useable to enlarge a penetration tract.
  • this distally advanceable debulking system 10 generally comprises a) a subselective sheath 12 , b) a distally-advanceable debulker 14 which is passable out of the subselective sheath, in a distal direction DD, and a counter-traction member 16 which is advanceable through the penetration tract ahead of the debulker 14 , and engageable with tissue adjacent the tract to exert a counter-force (i.e.
  • the counter-traction member 16 may similarly be positioned adjacent the tissue such that it does not actually exert force against the tissue until the debulker 14 is advanced into contact with the tissue, at which time the tissue will then be compressed between the debulker and the counter-traction member 16 as the debulking procedure is performed.
  • the subselective sheath 12 of the embodiment shown in the drawings comprises a flexible tube which is sized to be advanceable into the anatomical conduit from which the interstitial penetration tract extends.
  • the preferred subselective sheath 12 comprises inner wall 30 preferably formed of formed of polytetrafluoroethylene (PTFE), an outer wall 32 preferably formed of polyether block amide polymer (e.g., PebaxTM), and a braid 34 captured between inner 30 and outer 32 walls, such braid 34 terminating distally at a location which is approximately 2-10 mm from the distal end of the sheath 12 .
  • PTFE polytetrafluoroethylene
  • an outer wall 32 preferably formed of polyether block amide polymer (e.g., PebaxTM)
  • a braid 34 captured between inner 30 and outer 32 walls, such braid 34 terminating distally at a location which is approximately 2-10 mm from the distal end of the sheath 12 .
  • non-braided distal portion 36 of approximately 2-10 mm and a braided proximal portion 38 .
  • the presence of the braid 34 within the proximal portion 38 of the sheath 12 enhances its strength and resistance to crimping or kinking, while the non-braided distal portion 36 of the sheath 12 remains soft and pliable to avoid injury or damage to the walls of blood vessels or other tissues, as the sheath 12 is advanced.
  • the sheath 12 will preferably have an outer diameter of 0.050-0.150 inch and an inner lumen diameter of 0.040-0.140 inch.
  • the subselective sheath 12 may have lumen which curves laterally and exits through an outlet port formed in the sidewall of the sheath 12 .
  • Such side outlet sheath (not shown) may be advanced to a position where the side outlet aperture is in direct alignment with the penetration tract PT, and thereafter, the debulker 14 may be advanced out of the side outlet aperture and through the penetration tract PT.
  • debulker 14 comprises a rotating tissue cutter which, when advanced in the distal direction and concurrently rotated, will sever and remove a cylindrical mass of tissue from the region surrounding the penetration tract.
  • this preferred debulker 14 comprises a flexible tube 40 which has a lumen 44 extending longitudinally therethrough, and an annular cutting member 42 mounted on the distal end thereof.
  • the annular cutting member 42 has a sharpened leading edge 46 and a hollow bore 48 which extends therethrough.
  • the cutting member 42 is mounted securely on the distal end of the tube, preferably such that the bore 46 of the annular cutting member 42 is in direct axial alignment with the lumen 44 of the tube 40 , and the outer surface of the cutting member 42 is flush with the outer surface of the tube 40 .
  • the tube 40 is preferably formed of a flexible plastic (e.g., PebaxTM polyether block amide polymer).
  • the cutter member 42 is preferably formed of a rigid material such as stainless steel. In embodiments intended for use in coronary blood vessels, this debulker 14 will preferably have an outer diameter of 0.05-0.13 inches and an inner (lumen) diameter of 0.04-0.12 inches.
  • a plurality of bearing members 50 may be mounted at spaced-apart locations within the lumen 44 of the debulker 14 to facilitate rotation of the debulker 41 about a central shaft (e.g., the shaft 60 of the countertraction member 16 ).
  • a drive motor/handpiece 22 may be mounted on the proximal end of the debulker 14 , as shown in FIGS. 1 and 7. This drive motor/handpiece 22 , when actuated, will rotationally drive the debulker 14 , at a suitable rate of rotation to facilitate the desired severing of tissue. In applications where the debulker 14 is being used to sever soft tissue, it is preferable that the motor/handpeice 22 be capable of driving the debulker 14 at 60-300 revolutions per minute.
  • One example of a commercially available drive motor/handpiece 22 which may be used is the MDV Motor Drive Unit manufactured by DVI, Inc.
  • the counter-traction member 16 of the embodiment shown in the drawings serves to pass through the interstitial tract to be enlarged, ahead of the debulker, and prevents unwanted protrusion or “tenting” of the tissue into the adjacent anatomical conduit, thereby enhancing the tissue cutting efficience of the debulker.
  • the preferred counter-traction member 16 comprises an elongate, pliable shaft 60 having a dilator/tissue-engaging member 62 mounted on the distal end thereof, and a guidewire lumen 67 .
  • the tract dilator/tissue engaging member 62 comprises a frustoconical body 68 and a cutting-engagement plate 64 formed on the proximal end thereof.
  • the proximal surface 66 of the cutting-engagement plate 64 is disposed in a plane P which is substantially perpendicular to the longitudinal axis LA of the shaft 60 .
  • the frustoconical portion is preferably formed of soft plastic such as polyether block amide polymer (e.g., PebaxTM) and the cutting/engagement plate 64 is preferably formed of hard material such as polycarbonate or stainless steel. As shown in the exploded view of FIG.
  • a cavity 73 may be formed in the proximal end of the dilator/engagement plate 62 , including a shaft receiving portion 74 and an annular groove 70 .
  • the distal portion 65 of the cutter/engagement plate 64 is inserted into cavity 73 such that an annular shoulder 72 formed about the proximal portion 65 will frictionally engage a corresponding annular groove 70 formed about the interior of the cavity 73 , thereby holding the cutting/engagement plate 64 in fixed position on the distal end of the dilator/engagement member 62 .
  • the distal end of the shaft 60 is then inserted through the bore 67 of the cutting/engagement plate 64 until it bottoms out in the shaft receiving portion 74 of the cavity 73 .
  • An adhesive or thermal compression bonding may be used to securely hold the shaft in contact with the dilator/engagement member 62 .
  • the proximal portion 65 of the cutting/engagement plate 64 may act as a ferrule, exerting radial inward pressure against the shaft to frictionally hold the shaft in its inserted position within the cavity.
  • the counter-traction member 16 also acts to protect the adjacent vessel or luminal anatomical structure from iatrogenic trauma (e.g., perforation, laceration) as the debulker is advanced.
  • tissue-engaging members may be utilized in addition to, or as an alternative to the particular counter-traction member 16 shown in FIGS. 1-8.
  • Some examples of alternative types of countertraction members 16 a , 16 b , 16 c are shown in FIGS. 9 a - 9 c and 11 a - 11 h.
  • one alternative counter-traction member 16 a comprises a telescoping shaft 80 formed of a distal shaft portion 80 ′ and a proximal shaft portion 80 ′′, having a plurality of radially expandable members 82 disposed about the shaft 80 , as shown.
  • a guidewire lumen (not shown) extends longitudinally through the shaft 80 .
  • Each radially expandable member 82 has a distal end which is affixed to the distal shaft portion 80 ′ and a proximal end which is affixed to the proximal shaft portion 80 ′′. As shown in FIG.
  • another alternative counter-traction member 16 b comprises an elongate shaft 90 which has a guidewire lumen 92 and a balloon inflation/deflation lumen 94 extending therethrough, and a balloon 96 mounted thereon.
  • the shaft 90 With the balloon in its deflated state as shown in FIG. 10 a , the shaft 90 is advanceable over a guidwire and through the penetration tract PT which is to be enlarged. After the balloon 96 has emerged out of the opposite end of the penetration tract PT, inflation fluid is injected through the inflation/deflation lumen 94 to inflate the balloon 96 as shown in FIG. 10 c .
  • the inflated balloon 96 will the abut against and engage the tissue which surrounds the penetration tract PT, and will exert proximally directed force on such tissue while the debulker 14 is advanced through the tissue.
  • the shaft 90 will be fully retracted into the lumen 44 of the debulker 14 and the cutting surface 46 of the annular cutting member 42 will abut against a reinforced region 98 of the balloon.
  • Such reinforced region 98 is sufficiently resistant to cutting or puncture to prevent the annular cutting member 42 from bursting or penetrating through the wall of the balloon 96 .
  • FIGS. 11 f - 11 h there is shown yet another counter-traction member 16 c which comprises an elongate shaft 150 having a plurality of resilient or spring loaded, outwardly splayable members 160 which are attached at their distal ends to the shaft 150 .
  • the proximal ends of the splayable members 160 are biased to a radially expanded configuration as shown in FIGS. 11 f - 11 h , but are initially compressible to a radially compact configuration wherein they may be received within the lumen 44 of the debulker, as shown in FIG. 11 e .
  • the splayable members 160 are placed in their radially compact configuration and retracted at least partially within the lumen 44 of the tubular member 40 of the debulker 14 .
  • the shaft 150 is advanced in the distal direction to drive the splayable members 160 through the interstitial tract.
  • proximal ends of the splayable members emerge from the distal end of the interstitial tract, they will spring outwardly to their radially expanded configuration and will engage the tissue adjacent the distal end of the tract.
  • proximally directed pressure may be applied to the shaft as the debulker 40 is advanced in the distal direction. This results in the desired counter-traction on the tissue being severed by the annular cutting member 42 .
  • the leading edge 46 of the annular cutting member 42 will be nested within and in contact with the splayable members 160 , as shown in FIG. 11 h .
  • the tissue which has been severed from the area surrounding the interstitial tract will be received within the lumen 44 of the debulker, for subsequent removal from the body.
  • FIGS. 3 a - 3 d show a specific coronary revascularization procedure wherein an interstitial passageway is to be formed between a coronary vein CV and an adjacent coronary artery CA, to permit arterial blood to flow into the coronary vein CV.
  • a small guidewire GW is passed through such penetration tract PT.
  • the guidewire GW is passed, proximal end first, into the distal end of the guidewire lumen 67 which extends through the counter-traction member 16 .
  • the system 10 is advanced over the guidewire GW until the distal end of the subselective sheath 12 becomes positioned within the coronary vein CV at a location approximately 0.10 inch (i.e., 2-3 mm) from the penetration tract PT.
  • the counter-traction member is further advanced such that the dilator/engagement member 62 will pass through the penetration tract PT and into the coronary artery CA.
  • the tissue surrounding the penetration tract PT will elastically retract about the distal portion of the shaft and the proximal surface 66 of the cutting/engagement plate 64 will abut against the coronary artery wall immediately adjacent the opening of the penetration tract PT into the coronary artery CA.
  • proximally directed pressure is applied to the counter-traction member 16 while concurrently advancing the debulker 14 in the distal direction, as shown in FIG. 3 a.
  • the drive motor/handpiece 22 is actuated so as to rotate the debulker at approximately 60-300 RPM. As shown in FIG. 3 b , this causes the sharpened leading edge 46 of the cutting member 42 to cut a cylindrical bolus of tissue as the rotating debulker 14 continues to advance.
  • the application of proximally directed pressure on the counter-traction member 16 concurrently with the distally directed advancement of the debulker 14 prevents the surrounding tissue from “tenting” and enhances the cutting efficiency of the debulker 14 .
  • the severed bolus of tissue will be prevented from escaping into the coronary artery CA, and will be forced into the lumen of the debulker 14 whereby it may be extricated and removed from the body along with the debulker 14 , as illustrated in FIG. 3 c . This results in the formation of an enlarged bloodflow passageway EBP, as desired.
  • one or more embolic blockers B or other flow-blocking means may be utilized to prevent arterial blood which enters the coronary vein CV through the enlarged bloodflow passageway EBP from flowing in the venous return direction, and to cause such arterial blood to flow through the coronary vein CV in the retrograde direction, thereby bypassing the obstruction OB located in the adjacent coronary artery CA.
  • FIGS. 12 a - 12 b show an example of a retractable debulking-type tract enlargement system 10 a , of the present invention.
  • This system 10 a comprises a proximal counter-force member 112 in combination with a retractable debulker 14 a , as shown in FIGS. 12 a and 12 b.
  • the proximal counter-force member 112 comprises a tube having a lumen (not shown) which extends longitudinally therethrough and an annular cutting/engagement plate 100 formed on the distal end thereof.
  • the annular cutting/engagement plate 100 serves to engage a pull-back tissue cutter formed on the proximal end of the retractable debulker 14 a .
  • a plurality of bearings 50 of the type described hereabove may be coaxially disposed at spaced apart locations within the lumen of the proximal counter-force member 112 .
  • the retractable debulker 14 a of this embodiment comprises a shaft 102 having a flexible frusto-conical dilator 104 formed thereon, and an annular cutter member 106 mounted on the proximal end of the dilator 104 , as shown.
  • the frusto-conical dilator 104 may be constructed and configured the same as the frustoconical body 68 described hereabove.
  • the annular cutting member 106 may be constructed and configured the same as the annular cutting member 42 of the first embodiment described hereabove. This annular cutting member 106 has a sharpened proximal edge 108 which will sever tissue when retracted therethrough.
  • a guidewire lumen(not shown) extends longitudinally through the shaft 102 and through the frusto-conical dilator.
  • the retractable debulker 14 a may be rotatably driven by a drive motor/handpiece as described hereabove.
  • this retractable debulking type system 10 a Prior to operation, this retractable debulking type system 10 a is assembled such that shaft 100 the retractable debulked 14 a is slidably and (and in some cases rotatably) disposed within the lumen of the proximal counter-force member 112 .
  • the shaft 102 will extend through any bearings 50 disposed within the lumen of the counter-force member 112 .
  • the shaft 102 may initially be retracted such that the proximal sharpened edge 108 of the annular cutter, 106 is in abutment with the annular cutting plate 100 .
  • the counter-force member 112 and retractable debulker 14 a are positioned within the lumen 31 of a subselective sheath 12 as described hereabove. This system 10 a may then be utilized to enlarge a small penetration tract PT which has been formed through the sidewall of and extending outwardly from an anatomical conduit of the body, and through which a guidewire has been inserted.
  • the guidewire GW which extends through the penetration tract is inserted into the distal end of the guidewire lumen (not shown) of the retractable debulker 14 a .
  • the subselective sheath 12 having the counterforce member 112 and retractable debulker positioned therewith, is maneuvered into the anatomical conduit from which the penetration tract extends. Thereafter, the shaft 102 of the retractable debulker 14 a is advanced such that the dilator 104 is forced through the penetration tract. After the sharpened proximal edge 108 of the retractable debulker 14 a has emerged out of the opposite end of the penetration tract, the tissue which surrounds the penetration tract will elastically constrict about the shaft.
  • the counter-force member 112 is then advanced until the distal lo annular cutting plate 100 is in abutment with the wall of the portion of the wail of the anatomical conduit which surrounds the proximal end of the penetration tract.
  • distally directed counter-force is applied to the counter-force member 112 while the retractable debulker 14 a is retracted in the proximal direction.
  • the retractable debulker 14 a may be rotated concurrently with its retraction.
  • the sharpened proximal edge 108 of the annular cutting member 106 will sever a generally cylindrical bolus of tissue which surrounds the puncture tract, thereby accomplishing the desired enlargement of the initially formed penetration tract.
  • the severed bolus of tissue will be drawn into, and captured within, the lumen (not shown) of the counter-force member 112 as the sharpened proximal edge 108 of the annular cutting member 106 is retracted into contact with the annular cutting plate 100 .
  • the counter-force member 112 (having the severed bolus of tissue contained therewithin) and the retractable debulker 14 a , may be removed from the body along with the subselective sheath 12 .
  • the particular geometry of the cutter member 42 can assist in creation of the optimal passage, such as the enlarged bloodflow passageway EBP of the foregoing example.
  • the annular cutting member 42 need not be of circular cross-sectional configuration as shown in FIG. 7 a , but rather may be of oblong or oval configuration. Such oblong or oval shape of the annular cutting member 42 , when advanced through the puncture tract without rotation thereof, will form a channel of oval or oblong cross-sectional shape.
  • the annular cutting member 42 may be of tapered outer diameter, such that its distal cutting edge is of a first diameter d x and its proximal end is of a second diameter d y . Such tapering of the annular cutting member 42 causes the tissue which is cut by the cutting edge 46 to expand as the debulker 14 is advanced, thereby resulting in a more predictable diameter of the resultant channel.
  • certain types of energy e.g., laser, radio-frequency energy, electrical resistance heat, etc.
  • a tract-enlarging apparatus such as the debulker 14 , 14 a and/or counter-traction member 16 , 16 a , 16 c to enhance the tract-enlarging efficiency of the system.
  • Specific examples of systems which incorporate such energy emitting components are shown in FIGS. 10 a - 10 f.
  • FIGS. 10 a - 10 c show one energy-emitting debulking-type system which incorporates a bipolar, energy-emitting debulker 14 ′.
  • FIGS. 10 d - 10 f show another energy-emitting, debulking-type system wherein one electrode is located on an energy emitting debulker 14 ′′′ and another electrode is located on an energy-emitting counter-traction member 16 ′′′.
  • the bipolar, radiofrequency debulker 14 ′ comprises an elongate tubular member 40 ′ having a hollow lumen 44 ′ extending longitudinally therethrough.
  • First and second energy-transmitting members 204 a , 204 b extend longitudinally through the tubular member 44 ′, as shown in the cross sectional view of FIG. 10 c .
  • a debulking electrode tip 205 is mounted on the distal end of the tubular member.
  • Such electrode tip 205 incorporates a first radiofrequency-emitting electrode 206 and a second radiofrequency-emitting electrode 208 , as shown in FIG. 10 b .
  • the first energy transmitting member 204 a is connected to the first electrode 206 and the second energy transmitting member 204 b is connected to the second electrode 208 .
  • An annular insulator body 210 is disposed between the electrodes 204 a , 204 b .
  • a bipolar radiofrequency generator 200 is connected by way of a wire 202 to the first and second energy transmitting members 204 a , 204 b such that a circuit is completed between the generator 200 and the respective first and second electrodes 206 , 208 .
  • the generator may be energized to cause radiofrequency current to pass between the annular distal surfaces of the first and second electrodes 206 , 208 , thereby effecting bipolar cutting or ablation of the tissue which surrounds the interstitial tract.
  • the first electrode 206 a is mounted on the distal end of the debulker 14 ′′ and the second electrode 208 a is mounted on the proximal end of the countertraction member 16 ′′, as shown.
  • the first energy transmitting member 204 a extends through the tubular member 40 ′′ of the debulker 14 ′′ while the second energy transmitting member 204 b extends through the shaft 60 ′′ of the countertraction member 16 ′′.
  • the first energy transmitting member 204 a is connected to the first electrode 206 a of the second energy transmitting member 204 b is connected to the second electrode 208 a .
  • bipolar embodiments are shown in FIGS. 10 a - 10 f
  • similar monopolar embodiments may also be devised through the alternate use of a separate antenna or plate electrode which attaches to the patients body to complete the circuit.
  • Such monopolar embodiments may utilize only a single electrode 204 or 206 to accomplish the desired cutting or ablation of tissue.
  • the radiofrequency energy may be applied continuously at 100 KHz-2 MHz, and preferably at about 500 KHx (i.e., 70 watts) until the cutting operation is complete.
  • such radiofrequency energy may be delivered intermittently, in pulsed fashion, to avoid necrosis or damage to the adjacent tissue.
  • the duty cycle of the pulsed energy will optomized provide efficient tissue cutting while avoiding damage to surrounding tissue.
  • FIGS. 10 g - 10 i show variants of a laser emitting debulker 14 b , wherein laser energy is used to cut or vaporize the tissue.
  • the embodiment shown in FIGS. 10 g and 10 g ′ comprises an elongate flexible member having a guidewire lumen 73 extending longitudinally therethrough, and a plurality of longitudinally extending, parallel optical fiber bundles 71 disposed in a generally circular array about the outer perimeter of the member, such optical fiber bundles 71 terminating distally in lenses or other laser emitting surfaces 77 such that a generally conical or annular pattern of laser light is projected from the distal end of the debulker 14 b.
  • FIGS. 10 h and 10 h ′ show an alternative laser emitting debulker 14 b ′ wherein a central laser-transmitting optical fiber bundle 75 extends longitudinally a portion of the debulker 14 b ′ and terminates proximal to a generally conical cavity 76 formed in the distal end of the debulker 14 b ′.
  • a stationary prism 77 having a plurality of light guide grooves 78 formed thereabout, is mounted on the distal end of the fiber bundle 75 such that a generally conical pattern of laser light is projected from the prism, through the conical cavity 76 and out of the distal end of the debulker 14 b ′.
  • An optional suction lumen 79 may be provided in any of these laser embodiments, to enhance their efficiency (as described more fully herebelow) and/or to aspirate away any residue or tissue particle which become severed during the procedure.
  • FIGS. 10 i and 10 i ′ show another alternative laser emitting debulker 14 b ′′ wherein the central laser-transmitting optical fiber bundle 75 ′ is rotatable, terminates proximal to a generally conical cavity 76 formed in the distal end of the debulker 14 b ′.
  • negative pressure may be applied through the lumen of the debulker 14 , 14 a to a) tension the tissue being cut so as to improve the cutting efficiency and/or predictability of the cut and/or b) draw the severed tissue into the lumen of the debulker 14 , 14 a so as to capture and prevent escape of such severed tissue.
  • suction or negative pressure is applied through the lumen of the debulker 14 , 14 a
  • the operator may monitor the amount of negative pressure being generated as an indicator of whether the cutting tip 46 , 46 a is presently in contact with tissue. In this manner, the operator may promptly discern when the cutting tip 46 , 46 a has passed fully through the desired tissue and into the opposite blood vessel or other cavernous space.
  • an optional sensor apparatus may be incorporated into the system 10 , 10 a to provide feedback or signal(s) to enable the operator to determine when the debulking operation is complete so that the advancement or retraction of the debulker 14 , 14 a may be terminated at an appropriate time.
  • the sensor apparatus 126 may comprise any suitable type of sensor which will indicate when the cutting edge 46 of the annular cutting member 42 is no longer in contact With tissue. Examples of the types of sensor apparatus 126 which may be used include sensors which measure impedance, temperature and/or electromagnetic resistance. Additionally, in systems 10 , 10 a which utilize pulsed energy (FIG.
  • the temperature sensed by the sensor 126 may be used to manually or automatically (i.e., by a microprocessor or other controller) adjust the duty cycle of the pulsed energy to avoid exceeding a maximum desired temperature (e.g., the thermal necrosis temperature of the tissue-or some other temperature which has been identified as the maximum temperature to which the surrounding tissue may be heated).
  • a maximum desired temperature e.g., the thermal necrosis temperature of the tissue-or some other temperature which has been identified as the maximum temperature to which the surrounding tissue may be heated.
  • either of the debulking-type systems 10 , 10 a may include a force controlling apparatus 128 for controlling the force applied by the debulker 14 , 14 a upon the tissue being severed.
  • the debulker 14 has a flexible tubular shaft 40 formed of a proximal segment 40 a and a distal segment 40 b .
  • the distal segment 40 b is slidably received within the lumen of the proximal segment 40 a , as shown.
  • the force controlling apparatus 128 comprises a spring 130 which is attached to the proximal and distal portions 40 a , 40 b of the tube 40 such that, when the distal end of the debulker 14 is pressed against tissue, the spring 130 will compress, thereby normalizing or regulating the force which is applied to the tissue.
  • energy e.g., radiofrequency energy, resistance heat
  • first and second energy-transmission contacts 132 , 134 such that energy will be, emitted from the debulker only when the contacts 132 , 134 are in abuttment with each other.
  • FIGS. 12-12 c show a dilation-type tract enlarging system 10 b of the present invention.
  • This dilation-type system 10 b generally comprises a) a tubular member 120 having a distal tissue-abutting rim 122 , and a lumen 124 extending longitudinally therethrough and b) a shaft 126 having a balloon 128 mounted thereon, a guidewire lumen 130 extending longitudinally therethrough, and an inflation/deflation lumen 132 extending from the proximal end thereof to the interior of the balloon.
  • the system 10 b is advanced over the guidewire GW until the tissue abutment rim 122 abuts against or otherwise registers with tissue which surrounds or lies adjacent the proximal end of the penetration tract.
  • tissue abutment rim 122 abuts against or otherwise registers with tissue which surrounds or lies adjacent the proximal end of the penetration tract.
  • inflation fluid is passed into the balloon 128 through the inflation/deflation lumen 132 , causing the balloon 128 to inflate.
  • Such inflation of the balloon serves to dilate the tissue surrounding the penetration tract, thereby accomplishing the desired enlargement of the penetration tract.
  • the inflation fluid may be withdrawn from the balloon 128 and the system 10 b is withdrawn from the body.
  • FIGS. 17-18 b show tissue-cutting tract enlarging catheters 10 c of the present invention.
  • These tissue cutting catheters 10 c comprise a flexible catheter 700 having a tissue cutting distal tip 702 a or 702 b mounted thereon.
  • the tissue cutting distal tip 702 a is a generally cylindrical solid member which has a has a beveled leading edge 704 and a guidewire lumen 706 a extending longitudinally therethrough, as shown.
  • the tissue cutting distal tip 702 b has two (2) tapered lateral surfaces 709 a , 709 b which converge to form a distal end 710 .
  • a central guidewire lumen 706 b extends through the distal end 710 , as shown.
  • tissue cutting catheters 10 c may be advanced over a guidewire and through a small penetration tract, such that the beveled distal edge 704 or lateral surfaces 706 a & 706 b will slice or slit the tissue without actually removing any tissue.
  • FIG. 19 shows a two-catheter tract enlarging system 10 d which comprises a) a first catheter 500 having a tract-enlarging apparatus (not shown) (e.g., a debulker, dialtor or tissue-slicing member of the above-described nature) advanceable from an opening 504 at or near the distal end of the first catheter 500 , and b) a second catheter 502 which has an anvil member 506 (e.g., an abuttable surface or receiving cavity) which is sized and configured to correspond with the leading end of the tract-enlarging apparatus of the first catheter.
  • a tract-enlarging apparatus not shown
  • anvil member 506 e.g., an abuttable surface or receiving cavity
  • the first catheter 500 is positioned in one of the anatomical conduits V, and the second catheter is positioned in the other anatomical conduit A, with its anvil member 506 located next to the penetration tract or passageway PT which is to be enlarged. Thereafter, the tract enlarging apparatus (not shown) is advanced through the tract or passageway PT until it registers with (e.g., abuts against or is received with) the anvil member 506 of the second catheter.
  • the anvil member 506 serves to provide counterforce against the tissue adjacent the initially formed tract or passageway PT so as to prevent unwanted protrusion or “tenting” of the tissue into the second anatomical conduit A, and to ensure efficient cutting of the tissue in cases where a debulking or tissue slicing type tract enlarging apparatus is used.

Abstract

Methods, apparatus and systems for enlarging interstitial penetration tracts which have been formed between blood vessels or elsewhere within the body of a mammalian patient. Included are debulking-type tract enlarging systems, dilation-type tract enlarging systems, tissue-slicing-type tract enlarging systems and two-catheter-type tract enlarging systems.

Description

FIELD OF THE INVENTION
The present invention relates generally to medical devices and methods, and more specifically to transluminal devices, systems and methods which are useable to enlarge interstitial tracts (e.g., man made puncture tracts or small passageways) which extend between two (2) anatomical conduits (e.g., blood vessels) or otherwise through tissue(s) within a mammalian body.
BACKGROUND OF THE INVENTION
Applicant has devised several new medical procedures wherein passageway-forming catheters are advanced into anatomical conduits (e.g., blood vessels) and are used to create one or more interstitial passageways which extend outwardly, from the conduit in which the catheter is positioned, to another conduit or anatomical structure. Some of these procedures may be used to form flow-through passageways between the anatomical conduit (e.g., blood vessel) in which the passageway-forming catheter is positioned, and another anatomical conduit (e.g., another blood vessel) or a different location on the same anatomical conduit (e.g., a downstream site on the same blood vessel). Alternatively, these procedures may be used to form access passageways between the anatomical conduit (e.g., blood vessel, urethra, fallopian tube, etc.) and another anatomical structure (e.g., a tumor, organ, muscle, nerve, etc.).
In at least some of applicant's procedures, the interstitial passageway(s) are initially formed by advancing a tissue-penetrating element (e.g., a small diameter needle or a flow of tissue-penetrating energy) from the passageway-forming catheter, through the wall of the anatomical conduit in which the catheter is positioned, and into the target location. In some cases, the interstitial passageway which is formed by the initial passage of the tissue-penetration element from the passageway-forming catheter is of relatively small diameter-and must subsequently be enlarged (e.g., debulked, dilated, expanded, stretched) to accommodate the desired flow of biological fluid (e.g., blood) or passage of other substances/devices therethrough.
In particular, as described in applicant's earlier-filed U.S. patent applications Ser. Nos. 08/730,327 and 08/730,496, such enlargement of the initially formed interstitial passageway (e.g., penetration tract) may be particularly important when the procedure is being performed to by-pass an obstruction within a coronary artery. For example, in some of applicant's procedures, a primary interstitial passageway is formed between an obstructed coronary artery and an adjacent coronary vein, such that blood will flow from the obstructed artery into the adjacent coronary vein. In such applications, the arterial blood which enters the adjacent coronary vein through the primary interstitial passageway is allowed to retroperfuse the ischemic myocardium by retrograde flow through the coronary vein. In other of applicant's procedures, one or more secondary interstitial passageways are formed between the coronary vein into which the arterial blood has flowed and the obstructed artery (or some other coronary artery) to allow arterial blood which has entered the coronary vein to reenter the obstructed artery (or some other coronary artery), after having bypassed the arterial obstruction. Thus, in either of these interventional procedures, it is important that the primary and/or secondary interstitial passageway(s) remain patent and sufficiently large in diameter to support the continued flow of arterial blood to the myocardium. However, the task of enlarging the small diameter interstitial passageway(s) (e.g., puncture tracts) formed by the initial passage of the tissue-penetrating element presents numerous technical challenges.
The prior art has included a number of catheter-based devices which may be used to enlarge or remove obstructive matter from the lumen of a blood vessel or other anatomical conduit (e.g., a blood vessel). These devices include; atherectomy catheters, embolectomy catheters, balloon angioplasty catheters, laser ablation catheters, etc. However, these prior art lumen-enlarging/lumen-clearing devices have typically not been intended for use in small diameter puncture tracts which diverge at an angle from the conduit lumen in which the catheter is located, as is typically the case in applicant's above-summarized interventional procedures.
Accordingly, there exists a need for the design and development of a new device, system and method for enlarging interstitial penetration tracts (e.g., man-made punctures or small passageways) which extend between adjacent anatomical conduits (e.g., blood vessels) within a mammalian body.
SUMMARY OF THE INVENTION
The present invention provides devices which are useable in combination with each other (i.e., as a system) to enlarge an interstitial tract (e.g., a small diameter penetration tract through tissue) which extends from a blood vessel or other anatomical conduit of the body. The tract enlarging systems of the present invention generally fall into three (3) major classifications—1) debulking-type systems, 2) dilating-type systems, 3) slicing-type systems and 4) two-catheter systems.
In accordance with the invention, one debulking-type tract enlargement system (referred to herein as an “advanceable” debulker) generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough; b) a counter-traction member which is advanceable, i.) through the lumen of the tubular sheath and ii.) at least partially through the interstitial tract, such that the countertraction member engages or becomes positioned in relation to tissue which lies adjacent the interstitial tract to thereafter exert proximally-directed force upon such tissue; and, c) a debulker'(e.g., a tissue removing apparatus or flow of energy) which is advanceable out of the lumen of the sheath in a distal direction (i.e., substantially opposite the proximally-directed force being exerted by the counter-traction member) to remove tissue from the area adjacent the tract.
Further in accordance with the invention, there is provided another debulking-type tract enlargement system (referred to herein as a “retractable” debulker) generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough, and b) a pull-back debulker (e.g., a tissue-removing apparatus or flow of energy) which is i.) initially advanceable out of the lumen of the sheath in a distal direction so as to pass through the penetration tract which is to be enlarged, and ii.) thereafter retractable in the proximal direction so as to remove, tissue which lies adjacent the interstitial tract, thereby enlarging the interstitial tract.
Still further in accordance with the invention, there is provided a dilating-type tract enlargement system (referred to herein as a “dilating” system) which generally comprises: a) an elongate, pliable, tubular sheath sized for insertion into the lumen of an anatomical conduit from which the interstitial tract extends, said sheath having a lumen which extends longitudinally therethrough, and b) a dilator (e.g., an elongate member) having at least one tissue-dilating member (e.g., a tapered, frusto-conical member, balloon or radial deployable member(s)) formed thereon, such dilator being advanceable into the penetration tract which is to be enlarged, and is subsequently useable to dilate such penetration tract, thereby resulting in the desired enlargement thereof. A positioning surface may be formed on the dilator to abut against tissue which lies adjacent the passageway in a manner which will enable the operator to determine that the dilator has been advanced to its desired position and is properly located to allow the dilate the interstitial tract as desired.
Still further in accordance with the invention, there is provided a slicing-type tract enlargement system (referred to herein as a “tissue-slicing” system) which generally comprises a) an elongate shaft which is advanceable through the interstitial tract, and b) at least one tissue slicing member which extends or is extendable from the shaft to incise or cut tissue which lies adjacent the interstitial tract as the shaft is advanced and/or retracted through the tract. In some embodiments, the tissue slicing member(s) may be initially disposed in a radially compact configuration which is flush with, or only slightly protrusive beyond, the outer surface of the shaft, thereby allowing the shaft to be advanced through the interstitial tract without cutting or disrupting the surrounding tissue. Thereafter, the tissue slicing member(s) is/are shifted to a radially expanded configuration wherein such tissue-slicing member(s) extend or protrude laterally from the shaft so as to slice, incise or cut at least some of the tissue which surrounds the tract. The tissue-slicing member(s) need not be concentric about the shaft, but rather may be of substantially flat configuration so as to create a defined incision or cut in the tissue. Moreover, the tissue-slicing member(s) may be configured so as not to completely sever and remove tissue in the manner of the above-summarized debulking-type embodiment, but rather may simply form a lit or incision adjacent the tract such that the surrounding tissue will continuously or intermittently separate to allow flow of fluid (e.g., blood) therethrough.
Still further in accordance with the invention, there is provided a two-catheter type tract enlarging system (referred to herein as a “two-catheter” system) which is specifically useable to enlarge an interstitial tract or passageway which has been formed between two adjacent anatomical conduits (e.g., blood vessels). Such two-catheter system generally comprises a) a first catheter having a tract-enlarging apparatus (e.g., a debulker, dialtor or tissue-slicing member of the above-described nature) which is advanceable from an opening at or near the distal end of that catheter, and b) a second catheter which has an anvil member (e.g., an abuttable surface or receiving cavity) which is sized and configured to correspond with the leading end of the tract-enlarging apparatus of the first catheter. The first catheter is positioned in one of the anatomical conduits, and the second catheter is positioned in the other anatomical conduit, with its anvil member located next to the interstitial tract or passageway which is to be enlarged. Thereafter, the tract enlarging, apparatus is advanced through the tract or passageway until it registers with (e.g., abuts against or is received with) the anvil member of the second catheter. As the tract enlarging apparatus is being advanced, the anvil member serves to provide counterforce against the tissue adjacent the initially formed tract or passageway so as to prevent unwanted protrusion or “tenting” of the tissue into the second anatomical conduit, and to ensure efficient cutting of the tissue in cases where a debulking or tissue slicing type tract enlarging apparatus is used.
Still further in accordance with the invention, either the debulking-type, dilating type, tissue-slicing type or two catheter type tract enlargement systems of the present invention may incorporate a guidewire lumen which extends longitudinally through the i.) tract enlarging member (e.g., debulker, dilator or tissue slicing member) to permit the tract enlarging member to be advanced over a small guidewire which has previously been passed through the penetration tract which is to be enlarged. Thus, the provision of such guidewire lumen may permit the system to be used to dilate penetration tracts which are of extremely small diameter, or which have become substantially closed off due to constriction of the surrounding tissue, provided that a guidewire was previously inserted through such penetration tract.
Still further in accordance with the invention, energy such as radio-frequency energy or electrical resistance heat may be applied to the tract enlarging member (e.g., debulker, dilator, or tissue slicing member) to enhance the tract-enlarging efficiency thereof.
Still further objects and advantages of the present invention will become apparent to those of skill in the relevant art, upon reading and understanding of the following detailed description of the invention and the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a perspective view of a debulking-type tract enlarging system of the present invention.
FIG. 2 is a schematic perspective view of a human body having the tract enlarging system of FIG. 1 operatively inserted into the coronary vasculature.
FIG. 2a is an enlarged, cut-away view of segment 2 a2 a of FIG. 2.
FIG. 3 is an enlarged sectional view through line 33 of FIG. 2a.
FIGS. 3a-3 d are step-wise showings of a presently preferred method for using the tract enlarging system of FIG. 1 to debulk and enlarge an interstitial penetration tract which has been created between a coronary artery and an adjacent coronary vein.
FIG. 4 is an enlarged, side elevational view of the distal portion of the tract enlarging system of FIG. 1.
FIG. 4a is a cross sectional view through line 4 a4 a of FIG. 4.
FIG. 4b is a cross sectional view through line 4 b4 b of FIG. 4.
FIG. 4c is a cross sectional view through line 4 c4 c of FIG. 4.
FIG. 5a is a side elevational view of the distal portion of the tract enlarging system of FIG. 1 disposed in a retracted configuration.
FIG. 5b is a side elevational view of the distal portion of the tract enlarging system of FIG. 1 disposed in a retracted configuration.
FIG. 6 is a is a longitudinal sectional view of the distal portion of the subselective sheath component of the system of FIG. 1.
FIG. 7 is a is a longitudinal sectional view of the distal portion of the tissue cutter component of the system of FIG. 1.
FIG. 7a is an exploded, longitudinal sectional view of the distal potion of the tissue cutter of FIG. 7.
FIG. 8 is a side elevational view of the counter-traction member component of the system of FIG. 1.
FIG. 8a is an exploded, longitudinal sectional view of the distal potion of the counter-traction member of FIG. 8.
FIG. 9a shows a first alternative counter-traction member having a tissue-engaging member formed of radially expandable members, wherein the radially expandable members are in their collapsed configuration.
FIG. 9b shows the first alternative counter-traction member of FIG. 9a, with its radially expandable members in a partially expanded configuration.
FIG. 9c shows the first alternative counter-traction member of FIG. 9a, with its radially expandable members in their fully expanded configuration.
FIG. 10a is a side elevational view of a debulking-type tract enlarging system which is equipped with a first type of an energy emitting debulker (e.g., a radio-frequency system).
FIG. 10b is an enlarged perspective view in the distal end of the energy emitting debulker of FIG. 10.
FIG. 10c is a cross sectional view through line 10 c10 c of FIG. 10a.
FIG. 10d is a side elevational view of the distal portion of an another alternative debulking-type system which comprises an energy-emitting debulker in conjunction with an energy emitting counter-traction member, and wherein the energy emitting counter-traction member is in a retracted position.
FIG. 10e shows the system of FIG. 10c with its energy-emitting countertraction member in its extended position.
FIG. 10f is a cross sectional view through line 10 e10 e of FIG. 10d.
FIG. 10g is a partial side elevational view of another energy-emitting debulker which incorporates an annular array of laser-transmitting optical fibers.
FIG. 10g′ is a cross-sectional view through line 10 g′—10 g′ of FIG. 10g.
FIG. 10h is a partial side elevational view of another energy-emitting debulker having central laser-transmitting optical fiber (or fiber bundle) in combination with a frusto-conical prism which projects a generally conical pattern of laser light from the distal end of the device.
FIG. 10h′ is a cross-sectional view through line 10 h′—10 h′ of FIG. 10h.
FIG. 10i is a partial side elevational view of another energy-emitting debulker having a rotatable laser-transmitting optical fiber (or fiber bundle) and a frusto-conical prism which projects a single ray of laser light but which, when rotated, will form a generally conical laser light pattern.
FIG. 10i′ is a cross-sectional view through line 10 i′—10 i′ of FIG. 10i.
FIG. 11a shows a debulking-type tract enlarging system having a second alternative counter-traction member which comprises an inflatable tissue-engaging balloon, wherein the balloon is in its non-inflated, collapsed configuration.
FIG. 11b is a cross sectional view through line 11 b11 b of FIG. 11a.
FIG. 11c shows the second alternative counter-traction member of FIG. 11a, with its balloon in a fully inflated, expanded configuration.
FIG. 11d shows the second alternative countertraction member of FIG. 11a, with its balloon in its fully inflated, expanded configuration and the shaft fully retracted into the lumen of the debulker.
FIG. 11e shows a debulking-type tract enlarging system having an advanceable debulker and a third alternative counter-traction member comprising splayable tissue-engaging members, wherein the tissue-engaging members are in there radially collapsed, non-splayed configuration.
FIG. 11f shows the system of FIG. 11e with its tissue-engaging members in their splayed, radially expanded configuration.
FIG. 11g shows the system of FIG. 11f with its counter-traction member is fully advanced out of the debulker.
FIG. 11h shows the system of FIG. 11g wherein the tissue-engaging members are in their radially expanded configuration and the counter-traction member has been fully retracted such that the distal end of the debulker engages the interior of the expanded tissue-engaging members.
FIG. 12a is a side elevational view of the distal portion of a retractable debulking-type tract enlarging system of the present invention, wherein the retractable debulker is disposed in a distally extended position.
FIG. 12b is a view of the system of FIG. 12A, wherein the debulker is disposed in a partially retracted position.
FIG. 13 is a side elevational view of a dilation-type tract enlarging system of the present invention, disposed with its dilator (i.e. balloon) in a stowed (i.e., deflated) position.
FIG. 13a is view of the system of FIG. 13, disposed with its dilator (i.e., balloon) in an operative (i.e., inflated) position.
FIG. 13b is a cross sectional view through line 13 b13 b of FIG. 13. FIG. 13c is a cross sectional view through line 13 c13 c of FIG. 13.
FIG. 14 is a graphic illustration of a continuous emission of radiofrequency energy in accordance with the present invention.
FIG. 15 is a graphic illustration of intermittant or pulsed emission of radiofrequency energy in accordance with the present invention.
FIG. 16 is a longitudinal sectional view of the distal portion of a debulker of the present invention which incorporates an apparatus for controlling the pressure applied by the debulker and/or for signifying when the debulking procedure is complete.
FIG. 17 is a side elevational view of the distal portion of a tissue-cutting type of tract enlarging system of the present invention.
FIG. 18a is a side elevational view of an alternative tissue-cutting tip for the system of FIG. 17.
FIG. 18b is a top plan view of the alternative tissue-cutting tip of FIG. 18a.
FIG. 18c is a distal end view of the alternative tissue cutting tip of FIG. 18a.
FIG. 19 is a schematic showing of two adjacent blood vessels having a penetration tract formed therebetween, and a two-catheter tract enlarging system of the present invention operatively disposed therein to enlarge the penetration tract.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The preferred embodiments and examples described in the following paragraphs, and shown in the accompanying drawings, should be considered as exemplars, rather than limitations on the devices, systems and methods of the present invention.
The particular embodiments described in detail below include debulking-type tract enlarging systems 10 and 10 a, dilating-type tract enlargement systems 10 b, and tissue-slicing-type tract enlarging systems 10 c.
A. Debulking-Type Systems
Generally, the debulking- type systems 10, 10 a serve to remove (e.g., cut, sever, ablate, vaporize, etc.) tissue which surrounds or lies adjacent to the initially formed interstitial tract thereby enlarging the tract. The description set forth in the following paragraphs includes a distally advanceable debulking-type system 10 as well as a proximally retractable debulking-type system 10 a.
1. Advanceable Debulking-Type Systems
FIGS. 1-9 show a preferred, distally-advanceable debulking-type tract enlarging system 10 which is useable to enlarge a penetration tract. As shown in detail in FIGS. 4-8a, this distally advanceable debulking system 10 generally comprises a) a subselective sheath 12, b) a distally-advanceable debulker 14 which is passable out of the subselective sheath, in a distal direction DD, and a counter-traction member 16 which is advanceable through the penetration tract ahead of the debulker 14, and engageable with tissue adjacent the tract to exert a counter-force (i.e. a force directed in the proximal direction PD) upon the tissue which is to be severed by the distally advancing debulker 14. It is also to be understood that the counter-traction member 16 may similarly be positioned adjacent the tissue such that it does not actually exert force against the tissue until the debulker 14 is advanced into contact with the tissue, at which time the tissue will then be compressed between the debulker and the counter-traction member 16 as the debulking procedure is performed.
Subselective Sheath
The subselective sheath 12 of the embodiment shown in the drawings comprises a flexible tube which is sized to be advanceable into the anatomical conduit from which the interstitial penetration tract extends. With particular reference to the showings of FIGS. 4, 4 c and 6, the preferred subselective sheath 12 comprises inner wall 30 preferably formed of formed of polytetrafluoroethylene (PTFE), an outer wall 32 preferably formed of polyether block amide polymer (e.g., Pebax™), and a braid 34 captured between inner 30 and outer 32 walls, such braid 34 terminating distally at a location which is approximately 2-10 mm from the distal end of the sheath 12. In this manner, there is defined a non-braided distal portion 36 of approximately 2-10 mm and a braided proximal portion 38. The presence of the braid 34 within the proximal portion 38 of the sheath 12 enhances its strength and resistance to crimping or kinking, while the non-braided distal portion 36 of the sheath 12 remains soft and pliable to avoid injury or damage to the walls of blood vessels or other tissues, as the sheath 12 is advanced. For use in coronary blood vessels, the sheath 12 will preferably have an outer diameter of 0.050-0.150 inch and an inner lumen diameter of 0.040-0.140 inch.
In some embodiments, the subselective sheath 12 may have lumen which curves laterally and exits through an outlet port formed in the sidewall of the sheath 12. Such side outlet sheath (not shown) may be advanced to a position where the side outlet aperture is in direct alignment with the penetration tract PT, and thereafter, the debulker 14 may be advanced out of the side outlet aperture and through the penetration tract PT.
Advanceable Debulker
One type of debulker 14 comprises a rotating tissue cutter which, when advanced in the distal direction and concurrently rotated, will sever and remove a cylindrical mass of tissue from the region surrounding the penetration tract. With particular reference to the showings of FIGS. 7 and 7a, this preferred debulker 14 comprises a flexible tube 40 which has a lumen 44 extending longitudinally therethrough, and an annular cutting member 42 mounted on the distal end thereof. The annular cutting member 42 has a sharpened leading edge 46 and a hollow bore 48 which extends therethrough. The cutting member 42 is mounted securely on the distal end of the tube, preferably such that the bore 46 of the annular cutting member 42 is in direct axial alignment with the lumen 44 of the tube 40, and the outer surface of the cutting member 42 is flush with the outer surface of the tube 40. The tube 40 is preferably formed of a flexible plastic (e.g., Pebax™ polyether block amide polymer). The cutter member 42 is preferably formed of a rigid material such as stainless steel. In embodiments intended for use in coronary blood vessels, this debulker 14 will preferably have an outer diameter of 0.05-0.13 inches and an inner (lumen) diameter of 0.04-0.12 inches. A plurality of bearing members 50 may be mounted at spaced-apart locations within the lumen 44 of the debulker 14 to facilitate rotation of the debulker 41 about a central shaft (e.g., the shaft 60 of the countertraction member 16). A drive motor/handpiece 22 may be mounted on the proximal end of the debulker 14, as shown in FIGS. 1 and 7. This drive motor/handpiece 22, when actuated, will rotationally drive the debulker 14, at a suitable rate of rotation to facilitate the desired severing of tissue. In applications where the debulker 14 is being used to sever soft tissue, it is preferable that the motor/handpeice 22 be capable of driving the debulker 14 at 60-300 revolutions per minute. One example of a commercially available drive motor/handpiece 22 which may be used is the MDV Motor Drive Unit manufactured by DVI, Inc.
Counter-traction Member
The counter-traction member 16 of the embodiment shown in the drawings serves to pass through the interstitial tract to be enlarged, ahead of the debulker, and prevents unwanted protrusion or “tenting” of the tissue into the adjacent anatomical conduit, thereby enhancing the tissue cutting efficience of the debulker. With particular reference to the showings of FIGS. 4, 4 a, 8 and 8 a, the preferred counter-traction member 16 comprises an elongate, pliable shaft 60 having a dilator/tissue-engaging member 62 mounted on the distal end thereof, and a guidewire lumen 67. The tract dilator/tissue engaging member 62 comprises a frustoconical body 68 and a cutting-engagement plate 64 formed on the proximal end thereof. The proximal surface 66 of the cutting-engagement plate 64 is disposed in a plane P which is substantially perpendicular to the longitudinal axis LA of the shaft 60. The frustoconical portion is preferably formed of soft plastic such as polyether block amide polymer (e.g., Pebax™) and the cutting/engagement plate 64 is preferably formed of hard material such as polycarbonate or stainless steel. As shown in the exploded view of FIG. 8a, a cavity 73 may be formed in the proximal end of the dilator/engagement plate 62, including a shaft receiving portion 74 and an annular groove 70. The distal portion 65 of the cutter/engagement plate 64 is inserted into cavity 73 such that an annular shoulder 72 formed about the proximal portion 65 will frictionally engage a corresponding annular groove 70 formed about the interior of the cavity 73, thereby holding the cutting/engagement plate 64 in fixed position on the distal end of the dilator/engagement member 62. The distal end of the shaft 60 is then inserted through the bore 67 of the cutting/engagement plate 64 until it bottoms out in the shaft receiving portion 74 of the cavity 73. An adhesive or thermal compression bonding may be used to securely hold the shaft in contact with the dilator/engagement member 62. Additionally or alternatively, the proximal portion 65 of the cutting/engagement plate 64 may act as a ferrule, exerting radial inward pressure against the shaft to frictionally hold the shaft in its inserted position within the cavity. The counter-traction member 16 also acts to protect the adjacent vessel or luminal anatomical structure from iatrogenic trauma (e.g., perforation, laceration) as the debulker is advanced.
It is to be appreciated that various other types of tissue-engaging members may be utilized in addition to, or as an alternative to the particular counter-traction member 16 shown in FIGS. 1-8. Some examples of alternative types of countertraction members 16 a, 16 b, 16 c are shown in FIGS. 9a-9 c and 11 a-11 h.
With reference to FIGS. 9a-9 c one alternative counter-traction member 16 a comprises a telescoping shaft 80 formed of a distal shaft portion 80′ and a proximal shaft portion 80″, having a plurality of radially expandable members 82 disposed about the shaft 80, as shown. Preferably, a guidewire lumen (not shown) extends longitudinally through the shaft 80. Each radially expandable member 82 has a distal end which is affixed to the distal shaft portion 80′ and a proximal end which is affixed to the proximal shaft portion 80″. As shown in FIG. 9a, when the distal shaft portion 80′ is fully advanced in the distal direction, the radially expandable members will be in a radially collapsed configuration of diameter D, which is sufficiently small to be advanceable through the previously formed penetration tract. Thereafter, as shown in FIGS. 9b and 9 c, the distal shaft portion 80′ may be retracted into the proximal shaft portion 80″ to cause the radially expandable members to bow or expand outwardly. Thus, when the distal shaft portion 80′ is partially retracted the radially expandable members 82 may assume a partially expanded configuration of diameter D2 when the distal shaft member 80′ is fully retracted the radially expandable members 82 will assume a fully expanded configuration of diameter D3.
Referring to FIGS. 11a-11 d, another alternative counter-traction member 16 b comprises an elongate shaft 90 which has a guidewire lumen 92 and a balloon inflation/deflation lumen 94 extending therethrough, and a balloon 96 mounted thereon. With the balloon in its deflated state as shown in FIG. 10a, the shaft 90 is advanceable over a guidwire and through the penetration tract PT which is to be enlarged. After the balloon 96 has emerged out of the opposite end of the penetration tract PT, inflation fluid is injected through the inflation/deflation lumen 94 to inflate the balloon 96 as shown in FIG. 10c. As described in more detail herebelow, the inflated balloon 96 will the abut against and engage the tissue which surrounds the penetration tract PT, and will exert proximally directed force on such tissue while the debulker 14 is advanced through the tissue. As shown in FIG. 10d, after the tissue has been fully severed, the shaft 90 will be fully retracted into the lumen 44 of the debulker 14 and the cutting surface 46 of the annular cutting member 42 will abut against a reinforced region 98 of the balloon. Such reinforced region 98 is sufficiently resistant to cutting or puncture to prevent the annular cutting member 42 from bursting or penetrating through the wall of the balloon 96. Referring to FIGS. 11e-11 h, there is shown yet another counter-traction member 16 c which comprises an elongate shaft 150 having a plurality of resilient or spring loaded, outwardly splayable members 160 which are attached at their distal ends to the shaft 150. The proximal ends of the splayable members 160 are biased to a radially expanded configuration as shown in FIGS. 11f-11 h, but are initially compressible to a radially compact configuration wherein they may be received within the lumen 44 of the debulker, as shown in FIG. 11e. Initially, with the splayable members 160 are placed in their radially compact configuration and retracted at least partially within the lumen 44 of the tubular member 40 of the debulker 14. After the system has been inserted in the body and positioned adjacent the interstitial tract to be enlarged, the shaft 150 is advanced in the distal direction to drive the splayable members 160 through the interstitial tract. As the proximal ends of the splayable members emerge from the distal end of the interstitial tract, they will spring outwardly to their radially expanded configuration and will engage the tissue adjacent the distal end of the tract. Thereafter, proximally directed pressure may be applied to the shaft as the debulker 40 is advanced in the distal direction. This results in the desired counter-traction on the tissue being severed by the annular cutting member 42. At it end of the tract enlarging procedure, the leading edge 46 of the annular cutting member 42 will be nested within and in contact with the splayable members 160, as shown in FIG. 11h. In this manner, as will be more fully appreciated after reading the explanation of the detailed operation of the device set forth herebelow, the tissue which has been severed from the area surrounding the interstitial tract will be received within the lumen 44 of the debulker, for subsequent removal from the body.
Operation of the Distally Advanceable Debulking-type System
Prior to operation, the system 10 is assembled in the manner shown in FIG. 5a, such that the shaft 60 of the counter-traction member 16 is slidably and rotatably disposed within the lumen 44 of the debulker 14 (i.e. extending through the bearings 50 located within the lumen 44 of the debulker 14) and the countertraction member 16 and debulker 14 are positioned within the lumen 31 of the sheath 12. This system 10 may then be utilized to enlarge a small penetration tract PT which has been formed between an anatomical conduit and some other anatomical conduit or cavity within the body. For purposes of illustrating and explaining the operation of the present invention, FIGS. 3a-3 d show a specific coronary revascularization procedure wherein an interstitial passageway is to be formed between a coronary vein CV and an adjacent coronary artery CA, to permit arterial blood to flow into the coronary vein CV.
With reference to FIGS. 3a-3 d, after an interstitial penetration tract PT has been formed between a coronary artery CA and coronary vein CV, a small guidewire GW is passed through such penetration tract PT. The guidewire GW is passed, proximal end first, into the distal end of the guidewire lumen 67 which extends through the counter-traction member 16. With the debulker 14 and countertraction member 16 disposed within the lumen 31 of the subselective sheath 12, the system 10 is advanced over the guidewire GW until the distal end of the subselective sheath 12 becomes positioned within the coronary vein CV at a location approximately 0.10 inch (i.e., 2-3 mm) from the penetration tract PT. Thereafter, as shown in FIG. 3, the counter-traction member is further advanced such that the dilator/engagement member 62 will pass through the penetration tract PT and into the coronary artery CA. As the dilator/engagement member emerges into the lumen of the coronary artery CA the tissue surrounding the penetration tract PT will elastically retract about the distal portion of the shaft and the proximal surface 66 of the cutting/engagement plate 64 will abut against the coronary artery wall immediately adjacent the opening of the penetration tract PT into the coronary artery CA. Thereafter, proximally directed pressure is applied to the counter-traction member 16 while concurrently advancing the debulker 14 in the distal direction, as shown in FIG. 3a. As the advancing debulker 14 comes into contact with the tissue which surrounds the penetration tract PT, the drive motor/handpiece 22 is actuated so as to rotate the debulker at approximately 60-300 RPM. As shown in FIG. 3b, this causes the sharpened leading edge 46 of the cutting member 42 to cut a cylindrical bolus of tissue as the rotating debulker 14 continues to advance. The application of proximally directed pressure on the counter-traction member 16 concurrently with the distally directed advancement of the debulker 14 prevents the surrounding tissue from “tenting” and enhances the cutting efficiency of the debulker 14. Also, because the tissue which is being severed is located directly behind the cutting/engagement plate 64, the severed bolus of tissue will be prevented from escaping into the coronary artery CA, and will be forced into the lumen of the debulker 14 whereby it may be extricated and removed from the body along with the debulker 14, as illustrated in FIG. 3c. This results in the formation of an enlarged bloodflow passageway EBP, as desired.
As shown in FIG. 3d, and in accordance with applicants methodology described in earlier-filed U.S. patent applications Ser. Nos. 08/730,327 and 08/730,496, one or more embolic blockers B or other flow-blocking means may be utilized to prevent arterial blood which enters the coronary vein CV through the enlarged bloodflow passageway EBP from flowing in the venous return direction, and to cause such arterial blood to flow through the coronary vein CV in the retrograde direction, thereby bypassing the obstruction OB located in the adjacent coronary artery CA.
2. Retractable Debulking-type Systems
FIGS. 12a-12 b show an example of a retractable debulking-type tract enlargement system 10 a, of the present invention. This system 10 a comprises a proximal counter-force member 112 in combination with a retractable debulker 14 a, as shown in FIGS. 12a and 12 b.
Proximal Counter-force Member
The proximal counter-force member 112 comprises a tube having a lumen (not shown) which extends longitudinally therethrough and an annular cutting/engagement plate 100 formed on the distal end thereof. The annular cutting/engagement plate 100 serves to engage a pull-back tissue cutter formed on the proximal end of the retractable debulker 14 a. In embodiments where the retractable debulker is rotatable, a plurality of bearings 50 of the type described hereabove may be coaxially disposed at spaced apart locations within the lumen of the proximal counter-force member 112.
Retractable Debulker
The retractable debulker 14 a of this embodiment comprises a shaft 102 having a flexible frusto-conical dilator 104 formed thereon, and an annular cutter member 106 mounted on the proximal end of the dilator 104, as shown. The frusto-conical dilator 104 may be constructed and configured the same as the frustoconical body 68 described hereabove. The annular cutting member 106 may be constructed and configured the same as the annular cutting member 42 of the first embodiment described hereabove. This annular cutting member 106 has a sharpened proximal edge 108 which will sever tissue when retracted therethrough. A guidewire lumen(not shown) extends longitudinally through the shaft 102 and through the frusto-conical dilator. Optionally, the retractable debulker 14 a may be rotatably driven by a drive motor/handpiece as described hereabove.
Operation of the Retractable Debulker Type System
Prior to operation, this retractable debulking type system 10 a is assembled such that shaft 100 the retractable debulked 14 a is slidably and (and in some cases rotatably) disposed within the lumen of the proximal counter-force member 112. In embodiments wherein the debulker 14 a is rotatable, the shaft 102 will extend through any bearings 50 disposed within the lumen of the counter-force member 112. The shaft 102 may initially be retracted such that the proximal sharpened edge 108 of the annular cutter, 106 is in abutment with the annular cutting plate 100. The counter-force member 112 and retractable debulker 14 a are positioned within the lumen 31 of a subselective sheath 12 as described hereabove. This system 10 a may then be utilized to enlarge a small penetration tract PT which has been formed through the sidewall of and extending outwardly from an anatomical conduit of the body, and through which a guidewire has been inserted.
The guidewire GW which extends through the penetration tract is inserted into the distal end of the guidewire lumen (not shown) of the retractable debulker 14 a. The subselective sheath 12 having the counterforce member 112 and retractable debulker positioned therewith, is maneuvered into the anatomical conduit from which the penetration tract extends. Thereafter, the shaft 102 of the retractable debulker 14 a is advanced such that the dilator 104 is forced through the penetration tract. After the sharpened proximal edge 108 of the retractable debulker 14 a has emerged out of the opposite end of the penetration tract, the tissue which surrounds the penetration tract will elastically constrict about the shaft. The counter-force member 112 is then advanced until the distal lo annular cutting plate 100 is in abutment with the wall of the portion of the wail of the anatomical conduit which surrounds the proximal end of the penetration tract.
Thereafter, distally directed counter-force is applied to the counter-force member 112 while the retractable debulker 14 a is retracted in the proximal direction. Optionally, the retractable debulker 14 a may be rotated concurrently with its retraction. As the debulker 14 a is retracted, the sharpened proximal edge 108 of the annular cutting member 106 will sever a generally cylindrical bolus of tissue which surrounds the puncture tract, thereby accomplishing the desired enlargement of the initially formed penetration tract. The severed bolus of tissue will be drawn into, and captured within, the lumen (not shown) of the counter-force member 112 as the sharpened proximal edge 108 of the annular cutting member 106 is retracted into contact with the annular cutting plate 100.
Thereafter, the counter-force member 112 (having the severed bolus of tissue contained therewithin) and the retractable debulker 14 a, may be removed from the body along with the subselective sheath 12.
3. Sizing and Shaping of the Debulker to Optimize Flow Channel
In either debulking type system 10, 10 a the particular geometry of the cutter member 42 can assist in creation of the optimal passage, such as the enlarged bloodflow passageway EBP of the foregoing example. For example, the annular cutting member 42 need not be of circular cross-sectional configuration as shown in FIG. 7a, but rather may be of oblong or oval configuration. Such oblong or oval shape of the annular cutting member 42, when advanced through the puncture tract without rotation thereof, will form a channel of oval or oblong cross-sectional shape.
Also, as shown on FIG. 4, the annular cutting member 42 may be of tapered outer diameter, such that its distal cutting edge is of a first diameter dx and its proximal end is of a second diameter dy. Such tapering of the annular cutting member 42 causes the tissue which is cut by the cutting edge 46 to expand as the debulker 14 is advanced, thereby resulting in a more predictable diameter of the resultant channel.
4. Optional Energy-Delivery Features which may be Incorporated into Any of these Tract-Enlarging Systems
It will be appreciated that certain types of energy (e.g., laser, radio-frequency energy, electrical resistance heat, etc.) may be delivered to a tract-enlarging apparatus such as the debulker 14, 14 a and/or counter-traction member 16, 16 a, 16 c to enhance the tract-enlarging efficiency of the system. Specific examples of systems which incorporate such energy emitting components are shown in FIGS. 10a-10 f.
FIGS. 10a-10 c show one energy-emitting debulking-type system which incorporates a bipolar, energy-emitting debulker 14′. FIGS. 10d-10 f show another energy-emitting, debulking-type system wherein one electrode is located on an energy emitting debulker 14′″ and another electrode is located on an energy-emitting counter-traction member 16′″.
With reference to the particular embodiment shown in FIGS. 10a-10 c, the bipolar, radiofrequency debulker 14′ comprises an elongate tubular member 40′ having a hollow lumen 44′ extending longitudinally therethrough. First and second energy-transmitting members 204 a, 204 b extend longitudinally through the tubular member 44′, as shown in the cross sectional view of FIG. 10c. A debulking electrode tip 205 is mounted on the distal end of the tubular member. Such electrode tip 205 incorporates a first radiofrequency-emitting electrode 206 and a second radiofrequency-emitting electrode 208, as shown in FIG. 10b. The first energy transmitting member 204 a is connected to the first electrode 206 and the second energy transmitting member 204 b is connected to the second electrode 208. An annular insulator body 210 is disposed between the electrodes 204 a, 204 b. A bipolar radiofrequency generator 200 is connected by way of a wire 202 to the first and second energy transmitting members 204 a, 204 b such that a circuit is completed between the generator 200 and the respective first and second electrodes 206, 208. Thus, as the debulker is advanced in the distal direction through the interstitial passageway, the generator may be energized to cause radiofrequency current to pass between the annular distal surfaces of the first and second electrodes 206, 208, thereby effecting bipolar cutting or ablation of the tissue which surrounds the interstitial tract.
In the alternative bipolar energy-emitting system shown in FIGS. 10d-10 f, the first electrode 206 a is mounted on the distal end of the debulker 14″ and the second electrode 208 a is mounted on the proximal end of the countertraction member 16″, as shown. In this embodiment, the first energy transmitting member 204 a extends through the tubular member 40″ of the debulker 14″ while the second energy transmitting member 204 b extends through the shaft 60″ of the countertraction member 16″. Here again, the first energy transmitting member 204 a is connected to the first electrode 206 a of the second energy transmitting member 204 b is connected to the second electrode 208 a. In this manner when a bipolar radiofrequency generator 200 is connected to the energy transmitting members 204 a, 204 b, a circuit is completed between the generator and the first and second electrodes 206 a, 208 a such that radiofrequency current will pass between the electrodes 206 a, 206 b in a manner which cuts or ablates the tissue which surrounds the interstitial tract.
As those skilled in the art will appreciate, although bipolar embodiments are shown in FIGS. 10a-10 f, similar monopolar embodiments may also be devised through the alternate use of a separate antenna or plate electrode which attaches to the patients body to complete the circuit. Such monopolar embodiments may utilize only a single electrode 204 or 206 to accomplish the desired cutting or ablation of tissue.
In applications where radiofrequency energy is applied to the debulker 14, 14 a, the radiofrequency energy may be applied continuously at 100 KHz-2 MHz, and preferably at about 500 KHx (i.e., 70 watts) until the cutting operation is complete. Alternatively, such radiofrequency energy may be delivered intermittently, in pulsed fashion, to avoid necrosis or damage to the adjacent tissue. Preferably, as illustrated graphically in FIGS. 14a and 14 b, when pulsed radiofrequency energy is used in lieu of continuous energy, the duty cycle of the pulsed energy will optomized provide efficient tissue cutting while avoiding damage to surrounding tissue.
FIGS. 10g-10 i show variants of a laser emitting debulker 14 b, wherein laser energy is used to cut or vaporize the tissue. The embodiment shown in FIGS. 10g and 10 g′ comprises an elongate flexible member having a guidewire lumen 73 extending longitudinally therethrough, and a plurality of longitudinally extending, parallel optical fiber bundles 71 disposed in a generally circular array about the outer perimeter of the member, such optical fiber bundles 71 terminating distally in lenses or other laser emitting surfaces 77 such that a generally conical or annular pattern of laser light is projected from the distal end of the debulker 14 b.
FIGS. 10h and 10 h′ show an alternative laser emitting debulker 14 b′ wherein a central laser-transmitting optical fiber bundle 75 extends longitudinally a portion of the debulker 14 b′ and terminates proximal to a generally conical cavity 76 formed in the distal end of the debulker 14 b′. A stationary prism 77 having a plurality of light guide grooves 78 formed thereabout, is mounted on the distal end of the fiber bundle 75 such that a generally conical pattern of laser light is projected from the prism, through the conical cavity 76 and out of the distal end of the debulker 14 b′. An optional suction lumen 79 may be provided in any of these laser embodiments, to enhance their efficiency (as described more fully herebelow) and/or to aspirate away any residue or tissue particle which become severed during the procedure.
FIGS. 10i and 10 i′ show another alternative laser emitting debulker 14 b″ wherein the central laser-transmitting optical fiber bundle 75′ is rotatable, terminates proximal to a generally conical cavity 76 formed in the distal end of the debulker 14 b′. A stationary prism 77 having a single light guide groove 78 formed thereon as shown, is mounted on the distal end of the rotatable fiber bundle 75′ such that as laser energy is passed through the optical fiber bundle 75′ concurrently with its rotation, a generally conical pattern of laser light will be projected from the rotating prism mounted on the end of the rotating fiber bundle 75′, and such laser light pattern will be projected through the conical cavity 76′ and out of the distal end of the debulker 14 b″.
4. Optional Application of Negative Pressure Through Debulker Lumen
In either embodiment of the debulking- type system 10, 10 a, negative pressure may be applied through the lumen of the debulker 14, 14 a to a) tension the tissue being cut so as to improve the cutting efficiency and/or predictability of the cut and/or b) draw the severed tissue into the lumen of the debulker 14, 14 a so as to capture and prevent escape of such severed tissue. Additionally, when suction or negative pressure is applied through the lumen of the debulker 14, 14 a, the operator may monitor the amount of negative pressure being generated as an indicator of whether the cutting tip 46, 46 a is presently in contact with tissue. In this manner, the operator may promptly discern when the cutting tip 46, 46 a has passed fully through the desired tissue and into the opposite blood vessel or other cavernous space.
5. Optional Apparatus for Enabling Operator to Determine When Debulking Operation is Complete
In either debulking- type system 10, 10 a, an optional sensor apparatus may be incorporated into the system 10, 10 a to provide feedback or signal(s) to enable the operator to determine when the debulking operation is complete so that the advancement or retraction of the debulker 14, 14 a may be terminated at an appropriate time. As shown in FIG. 16, the sensor apparatus 126 may comprise any suitable type of sensor which will indicate when the cutting edge 46 of the annular cutting member 42 is no longer in contact With tissue. Examples of the types of sensor apparatus 126 which may be used include sensors which measure impedance, temperature and/or electromagnetic resistance. Additionally, in systems 10, 10 a which utilize pulsed energy (FIG. 15) in combination with a temperature sensor 126, the temperature sensed by the sensor 126 may be used to manually or automatically (i.e., by a microprocessor or other controller) adjust the duty cycle of the pulsed energy to avoid exceeding a maximum desired temperature (e.g., the thermal necrosis temperature of the tissue-or some other temperature which has been identified as the maximum temperature to which the surrounding tissue may be heated).
6. Optional Apparatus for Controlling the Force Applied by the Debulker
As shown in FIG. 16, either of the debulking- type systems 10, 10 a may include a force controlling apparatus 128 for controlling the force applied by the debulker 14, 14 a upon the tissue being severed. In the particular embodiment shown the debulker 14 has a flexible tubular shaft 40 formed of a proximal segment 40 a and a distal segment 40 b. The distal segment 40 b is slidably received within the lumen of the proximal segment 40 a, as shown. The force controlling apparatus 128 comprises a spring 130 which is attached to the proximal and distal portions 40 a, 40 b of the tube 40 such that, when the distal end of the debulker 14 is pressed against tissue, the spring 130 will compress, thereby normalizing or regulating the force which is applied to the tissue. In embodiments where the debulker emits energy (e.g., radiofrequency energy, resistance heat), first and second energy- transmission contacts 132, 134 such that energy will be, emitted from the debulker only when the contacts 132, 134 are in abuttment with each other. In this manner, such contact can be maintained only so long as the debulker 14 is engaging tissue, and when the debulker 14 emerges into the other vessel of open space, the spring 130 will relax causing contacts 132,134 to separate and the flow of energy through the debulker 14 to cease.
B. Dilation-Type Systems
FIGS. 12-12c show a dilation-type tract enlarging system 10 b of the present invention.
This dilation-type system 10 b generally comprises a) a tubular member 120 having a distal tissue-abutting rim 122, and a lumen 124 extending longitudinally therethrough and b) a shaft 126 having a balloon 128 mounted thereon, a guidewire lumen 130 extending longitudinally therethrough, and an inflation/deflation lumen 132 extending from the proximal end thereof to the interior of the balloon. A guidewire which has previously been passed through the penetration tract which is to be enlarged, is inserted into the distal end of the guidewire lumen 130. Thereafter, with the balloon 128 in its deflated state (FIG. 12) and the balloon-bearing portion of the shaft 126 positioned ahead of the tissue abutment rim 122, the system 10 b is advanced over the guidewire GW until the tissue abutment rim 122 abuts against or otherwise registers with tissue which surrounds or lies adjacent the proximal end of the penetration tract. Such abutment of the rim 122 against the tissue at the proximal end of the tract will deter further advancement of the system 10 b, and will signify to the operator that the balloon 128 has become positioned within the penetration tract. Thereafter, inflation fluid is passed into the balloon 128 through the inflation/deflation lumen 132, causing the balloon 128 to inflate. Such inflation of the balloon serves to dilate the tissue surrounding the penetration tract, thereby accomplishing the desired enlargement of the penetration tract. After the desired dilation of the penetration tract has been completed, the inflation fluid may be withdrawn from the balloon 128 and the system 10 b is withdrawn from the body.
C. TISSUE-SLICING TYPE SYSTEMS
FIGS. 17-18b show tissue-cutting tract enlarging catheters 10 c of the present invention. These tissue cutting catheters 10 c comprise a flexible catheter 700 having a tissue cutting distal tip 702 a or 702 b mounted thereon.
In the embodiment shown in FIG. 17, the tissue cutting distal tip 702 a is a generally cylindrical solid member which has a has a beveled leading edge 704 and a guidewire lumen 706 a extending longitudinally therethrough, as shown.
In the embodiment shown in FIGS. 18a-18 c, the tissue cutting distal tip 702 b has two (2) tapered lateral surfaces 709 a, 709 b which converge to form a distal end 710. A central guidewire lumen 706 b extends through the distal end 710, as shown.
These tissue cutting catheters 10 c may be advanced over a guidewire and through a small penetration tract, such that the beveled distal edge 704 or lateral surfaces 706 a & 706 b will slice or slit the tissue without actually removing any tissue.
D. Two Catheter Tract-Enlarging Systems
FIG. 19 shows a two-catheter tract enlarging system 10 d which comprises a) a first catheter 500 having a tract-enlarging apparatus (not shown) (e.g., a debulker, dialtor or tissue-slicing member of the above-described nature) advanceable from an opening 504 at or near the distal end of the first catheter 500, and b) a second catheter 502 which has an anvil member 506 (e.g., an abuttable surface or receiving cavity) which is sized and configured to correspond with the leading end of the tract-enlarging apparatus of the first catheter. The first catheter 500 is positioned in one of the anatomical conduits V, and the second catheter is positioned in the other anatomical conduit A, with its anvil member 506 located next to the penetration tract or passageway PT which is to be enlarged. Thereafter, the tract enlarging apparatus (not shown) is advanced through the tract or passageway PT until it registers with (e.g., abuts against or is received with) the anvil member 506 of the second catheter. As the tract enlarging apparatus (not shown) is being advanced, the anvil member 506 serves to provide counterforce against the tissue adjacent the initially formed tract or passageway PT so as to prevent unwanted protrusion or “tenting” of the tissue into the second anatomical conduit A, and to ensure efficient cutting of the tissue in cases where a debulking or tissue slicing type tract enlarging apparatus is used.
Although exemplary embodiments of the present invention have been shown and described, it will be apparent to those having ordinary skill in the art that c number of changes, modifications, or alterations to the invention as describer herein may be made, none of which depart from the spirit of the present invention. All such changes, modifications and alterations should therefore be seen as within the scope of the present invention as described herein and recited in the following claims.

Claims (5)

What is claimed is:
1. A method of enlarging a penetration tract formed between first and second anatomical structures in a human or veterinary patient, the method comprising the steps of:
forming a penetration tract that extends through a wall of the first anatomical structure, through a wall of the second anatomical structure and through any tissue located between the first and second anatomical structures;
passing a guidewire into the penetration tract;
providing an elongate, flexible tubular member having a hollow lumen extending therethrough sized to receive a guidewire, the tubular member having near its distal tip a debulking member including an electrode tip having at least one radio frequency-emitting electrode suitable for ablating tissue;
passing the tubular member over the guidewire and into the penetration tract; and
energizing the electrode tip to ablate tissue and enlarge the penetration tract.
2. The method of claim 1, wherein the electrode tip is a monopolar electrode tip having just one electrode, and wherein the method further includes:
providing a second electrode;
contacting the second electrode to an extracorporeal location on the patient to complete an electrode tip circuit.
3. The method of claim 1, wherein the electrode tip is a bipolar electrode tip that includes a pair of the electrodes, and wherein the method further includes energizing the pair of electrodes to generate a radio frequency energy field for ablating tissue.
4. The method of claim 3, wherein the electrode tip includes a distal-most face on which the pair of electrodes are exposed.
5. The method of claim 4, wherein the pair of electrodes are both annular, so that the exposed portions of the electrodes are circular on the distal-most face of the electrode tip.
US09/056,589 1998-04-07 1998-04-07 Transluminal devices, systems and methods for enlarging interstitial penetration tracts Expired - Lifetime US6561998B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US09/056,589 US6561998B1 (en) 1998-04-07 1998-04-07 Transluminal devices, systems and methods for enlarging interstitial penetration tracts
IL13872499A IL138724A0 (en) 1998-04-07 1999-04-06 Transluminal device, systems and methods for enlarging interstitial penetration tracts
PCT/US1999/007518 WO1999051162A1 (en) 1998-04-07 1999-04-06 Transluminal devices, systems and methods for enlarging interstitial penetration tracts
JP2000541938A JP2002510522A (en) 1998-04-07 1999-04-06 Transluminal device, system and method for enlarging an intervening perforation
EP99916412A EP1069869A4 (en) 1998-04-07 1999-04-06 Transluminal devices, systems and methods for enlarging interstitial penetration tracts
AU34737/99A AU763400B2 (en) 1998-04-07 1999-04-06 Transluminal devices, systems and methods for enlarging interstitial penetration tracts
CA002326769A CA2326769A1 (en) 1998-04-07 1999-04-06 Transluminal devices, systems and methods for enlarging interstitial penetration tracts
US10/346,556 US20030181938A1 (en) 1998-04-07 2003-01-17 Transluminal devices, systems and methods for enlarging interstitial penetration tracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/056,589 US6561998B1 (en) 1998-04-07 1998-04-07 Transluminal devices, systems and methods for enlarging interstitial penetration tracts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/346,556 Continuation US20030181938A1 (en) 1998-04-07 2003-01-17 Transluminal devices, systems and methods for enlarging interstitial penetration tracts

Publications (1)

Publication Number Publication Date
US6561998B1 true US6561998B1 (en) 2003-05-13

Family

ID=22005419

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/056,589 Expired - Lifetime US6561998B1 (en) 1998-04-07 1998-04-07 Transluminal devices, systems and methods for enlarging interstitial penetration tracts
US10/346,556 Abandoned US20030181938A1 (en) 1998-04-07 2003-01-17 Transluminal devices, systems and methods for enlarging interstitial penetration tracts

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/346,556 Abandoned US20030181938A1 (en) 1998-04-07 2003-01-17 Transluminal devices, systems and methods for enlarging interstitial penetration tracts

Country Status (7)

Country Link
US (2) US6561998B1 (en)
EP (1) EP1069869A4 (en)
JP (1) JP2002510522A (en)
AU (1) AU763400B2 (en)
CA (1) CA2326769A1 (en)
IL (1) IL138724A0 (en)
WO (1) WO1999051162A1 (en)

Cited By (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020045928A1 (en) * 2000-05-04 2002-04-18 Percardia, Inc. Methods and devices for delivering a ventricular stent
US20020058897A1 (en) * 1998-09-10 2002-05-16 Percardia, Inc. Designs for left ventricular conduit
US20030105514A1 (en) * 1998-09-10 2003-06-05 Percardia, Inc. Designs for left ventricular conduit
US20030120195A1 (en) * 1998-01-13 2003-06-26 Lumend, Inc. Re-entry catheter
US20030137008A1 (en) * 2000-03-28 2003-07-24 Hidetoshi Nozaki Solid state imaging device having a photodiode and a MOSFET and method of manufacturing the same
US20030216681A1 (en) * 1998-06-29 2003-11-20 John Zhang Sheath for use with an ultrasound element
US20040010248A1 (en) * 2002-07-10 2004-01-15 Appling William M. Endovascular treatment device having a fiber tip spacer
US20040015193A1 (en) * 2002-04-11 2004-01-22 Transvascular, Inc. Devices and methods for transluminal or transthoracic interstitial electrode placement
US6694983B2 (en) 1998-09-10 2004-02-24 Percardia, Inc. Delivery methods for left ventricular conduit
US20040049171A1 (en) * 2002-09-09 2004-03-11 Heartstent Corporation Device for placing transmyocardial implant
US20040077988A1 (en) * 1998-08-27 2004-04-22 Heartstent Corporation Healing transmyocardial implant
US20040133969A1 (en) * 2003-01-10 2004-07-15 Tyler Pipe Company, A Division Of Ransom Industries, Lp Closet carrier system and method of assembly
US20040199228A1 (en) * 2003-01-03 2004-10-07 Wilson Richard R. Ultrasonic catheter with axial energy field
US20050209578A1 (en) * 2004-01-29 2005-09-22 Christian Evans Edward A Ultrasonic catheter with segmented fluid delivery
US20050215946A1 (en) * 2004-01-29 2005-09-29 Hansmann Douglas R Method and apparatus for detecting vascular conditions with a catheter
US20050278013A1 (en) * 2004-05-26 2005-12-15 Matthew Rust Method for endovascular bypass stent graft delivery
US20060106308A1 (en) * 2001-12-14 2006-05-18 Hansmann Douglas R Blood flow reestablishment determination
US20060111704A1 (en) * 2004-11-22 2006-05-25 Rox Medical, Inc. Devices, systems, and methods for energy assisted arterio-venous fistula creation
US20060241342A1 (en) * 2003-03-13 2006-10-26 Medtronic Transvascular, Inc. Optically guided penetration catheters and their methods of use
US20070032808A1 (en) * 2005-08-03 2007-02-08 Azam Anwar System and method for addressing total occlusion in a vascular environment
US20070093779A1 (en) * 2005-09-12 2007-04-26 Kugler Chad J Endovascular devices and methods
US20070093780A1 (en) * 2005-09-12 2007-04-26 Kugler Chad J Endovascular devices and methods for exploiting intramural space
US20070093783A1 (en) * 2005-09-12 2007-04-26 Kugler Chad J Endovascular devices and methods
US20070093781A1 (en) * 2005-09-12 2007-04-26 Kugler Chad J Endovascular devices and methods for exploiting intramural space
US20070161951A1 (en) * 2004-01-29 2007-07-12 Ekos Corporation Treatment of vascular occlusions using elevated temperatures
US20070255303A1 (en) * 2006-05-01 2007-11-01 Ethicon Endo-Surgery, Inc. Integrated Guidewire Needle Knife Device
US20080188843A1 (en) * 2002-07-10 2008-08-07 Appling William M Device and method for endovascular treatment for causing closure of a blood vessel
US20080194939A1 (en) * 2004-09-08 2008-08-14 Advotek Medical Devices Ltd. Minimally Invasive Surgical Appartus and Methods
US20080208180A1 (en) * 2002-07-10 2008-08-28 Cartier William A Endovascular treatment sheath having a heat insulative tip and method for using the same
US20080234693A1 (en) * 2007-03-21 2008-09-25 Ethicon Endo-Surgery, Inc. Endoscopic Tissue Resection Device
US20080287939A1 (en) * 2002-07-10 2008-11-20 Appling William M Endovascular thermal treatment device with flexible guide tip and method
US20090118673A1 (en) * 2007-11-07 2009-05-07 Jerett Creed Needle injection catheter
US20090124899A1 (en) * 2007-10-22 2009-05-14 Peter Alan Jacobs Methods and devices for crossing chronic total occlusions
US20090248049A1 (en) * 2008-03-25 2009-10-01 Medtronic Vascular, Inc. Methods for Treating Vulnerable Plaque
US20090254105A1 (en) * 2008-04-04 2009-10-08 Medtronic Vascular, Inc. Anastomotic connectors
US20090259174A1 (en) * 2008-04-15 2009-10-15 Medtronic Vascular, Inc. Methods and devices for treating vulnerable atherosclerotic plaque
US20090270890A1 (en) * 2008-04-28 2009-10-29 David Bryan Robinson Methods and apparatus for crossing occlusions in blood vessels
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US20100130835A1 (en) * 2008-09-30 2010-05-27 Rox Medical, Inc. Methods for screening and treating patients with compromised cardiopulmonary function
US7727178B2 (en) 2001-12-03 2010-06-01 Ekos Corporation Catheter with multiple ultrasound radiating members
US20100168733A1 (en) * 1996-09-20 2010-07-01 Novasys Medical, Inc. Treatment of tissue in sphincters, sinuses, and orifices
US20100174302A1 (en) * 1998-04-10 2010-07-08 Ev3 Endovascular, Inc. Rotational atherectomy system and methods of use
NL2002597C2 (en) * 2009-03-06 2010-09-07 Tobrix B V Endovascular treatment device, system for endovascular treatment and method of operating
US8192452B2 (en) 2009-05-14 2012-06-05 Tyco Healthcare Group Lp Easily cleaned atherectomy catheters and methods of use
US8192363B2 (en) 2006-10-27 2012-06-05 Ekos Corporation Catheter with multiple ultrasound radiating members
US8202246B2 (en) 2008-02-05 2012-06-19 Bridgepoint Medical, Inc. Crossing occlusions in blood vessels
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US8226674B2 (en) 2000-12-20 2012-07-24 Tyco Healthcare Group Lp Debulking catheters and methods
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US8337425B2 (en) 2008-02-05 2012-12-25 Bridgepoint Medical, Inc. Endovascular device with a tissue piercing distal probe and associated methods
US8414604B2 (en) 2008-10-13 2013-04-09 Covidien Lp Devices and methods for manipulating a catheter shaft
US8469979B2 (en) 2000-12-20 2013-06-25 Covidien Lp High capacity debulking catheter with distal driven cutting wheel
US8496677B2 (en) 2009-12-02 2013-07-30 Covidien Lp Methods and devices for cutting tissue
US8597315B2 (en) 1999-08-19 2013-12-03 Covidien Lp Atherectomy catheter with first and second imaging devices
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
US8808186B2 (en) 2010-11-11 2014-08-19 Covidien Lp Flexible debulking catheters with imaging and methods of use and manufacture
US8920450B2 (en) 2010-10-28 2014-12-30 Covidien Lp Material removal device and method of use
US8951276B2 (en) 2011-11-04 2015-02-10 Avenu Medical, Inc. Systems and methods for percutaneous intravascular access and guidewire placement
US8968284B2 (en) 2000-10-02 2015-03-03 Verathon Inc. Apparatus and methods for treating female urinary incontinence
US8992717B2 (en) 2011-09-01 2015-03-31 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US8998937B2 (en) 1999-08-19 2015-04-07 Covidien Lp Methods and devices for cutting tissue
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
US9028512B2 (en) 2009-12-11 2015-05-12 Covidien Lp Material removal device having improved material capture efficiency and methods of use
US9060802B2 (en) 2006-11-21 2015-06-23 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US9119662B2 (en) 2010-06-14 2015-09-01 Covidien Lp Material removal device and method of use
US9138230B1 (en) 2011-04-29 2015-09-22 Avenu Medical, Inc. Systems and methods for creating arteriovenous (AV) fistulas
US9199067B2 (en) 2009-01-29 2015-12-01 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US9320530B2 (en) 2013-03-13 2016-04-26 The Spectranetics Corporation Assisted cutting balloon
US9387311B1 (en) 2014-10-31 2016-07-12 Cerevasc, Llc Methods and systems for treating hydrocephalus
US9439728B2 (en) 2010-06-15 2016-09-13 Avenu Medical, Inc. Systems for creating arteriovenous (AV) fistulas
US9439710B2 (en) 2012-11-14 2016-09-13 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US9452015B2 (en) 2010-06-15 2016-09-27 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US9474562B2 (en) 2012-02-08 2016-10-25 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US9545263B2 (en) 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
US9687266B2 (en) 2009-04-29 2017-06-27 Covidien Lp Methods and devices for cutting and abrading tissue
US9737696B2 (en) 2014-01-15 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US9782562B2 (en) 2002-04-04 2017-10-10 Angiodynamics, Inc. Venous insufficiency treatment method
US9801647B2 (en) 2006-05-26 2017-10-31 Covidien Lp Catheter including cutting element and energy emitting element
US9814513B2 (en) 2011-06-30 2017-11-14 Angiodynamics, Inc. Endovascular plasma treatment device and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
US10070866B1 (en) 2013-08-01 2018-09-11 Avenu Medical, Inc. Percutaneous arterial to venous anastomosis clip application catheter system and methods
US10092742B2 (en) 2014-09-22 2018-10-09 Ekos Corporation Catheter system
US10201387B2 (en) 2013-03-13 2019-02-12 The Spectranetics Corporation Laser-induced fluid filled balloon catheter
US10213224B2 (en) 2014-06-27 2019-02-26 Covidien Lp Cleaning device for catheter and catheter including the same
US10272230B2 (en) 2015-10-30 2019-04-30 Cerevasc, Llc Systems and methods for treating hydrocephalus
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
US10470797B1 (en) 2018-07-17 2019-11-12 SlipStream, LLC Systems and methods for vascular access
US10499919B2 (en) 2015-08-21 2019-12-10 Avenu Medical, Inc. Systems and methods for percutaneous access and formation of arteriovenous fistulas
US10543308B2 (en) 2017-04-10 2020-01-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US10656025B2 (en) 2015-06-10 2020-05-19 Ekos Corporation Ultrasound catheter
US10772672B2 (en) 2014-03-06 2020-09-15 Avenu Medical, Inc. Systems and methods for percutaneous access and formation of arteriovenous fistulas
US10842567B2 (en) 2013-03-13 2020-11-24 The Spectranetics Corporation Laser-induced fluid filled balloon catheter
US10850078B2 (en) 2014-12-30 2020-12-01 The Spectranetics Corporation Electrically-induced fluid filled balloon catheter
US10888354B2 (en) 2006-11-21 2021-01-12 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US10898213B2 (en) 2014-12-30 2021-01-26 The Spectranetics Corporation Electrically-induced pressure wave emitting catheter sheath
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11013900B2 (en) 2018-03-08 2021-05-25 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
US11020141B2 (en) 2005-09-12 2021-06-01 Bridgepoint Medical, Inc. Endovascular devices and methods
US11058492B2 (en) 2014-12-30 2021-07-13 The Spectranetics Corporation Laser-induced pressure wave emitting catheter sheath
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11116943B2 (en) 2018-10-09 2021-09-14 Limflow Gmbh Methods for accessing pedal veins
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11207503B2 (en) 2016-11-11 2021-12-28 Avenu Medical, Inc. Systems and methods for percutaneous intravascular access and guidewire placement
US11246659B2 (en) 2014-08-25 2022-02-15 The Spectranetics Corporation Liquid laser-induced pressure wave emitting catheter sheath
US11278708B2 (en) 2014-01-15 2022-03-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US11298511B2 (en) 2006-11-21 2022-04-12 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11458290B2 (en) 2011-05-11 2022-10-04 Ekos Corporation Ultrasound system
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11576724B2 (en) 2011-02-24 2023-02-14 Eximo Medical Ltd. Hybrid catheter for vascular intervention
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US11612397B2 (en) 2019-11-01 2023-03-28 Limflow Gmbh Devices and methods for increasing blood perfusion to a distal extremity
US11672553B2 (en) 2007-06-22 2023-06-13 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
US11684420B2 (en) 2016-05-05 2023-06-27 Eximo Medical Ltd. Apparatus and methods for resecting and/or ablating an undesired tissue
US11925367B2 (en) 2007-01-08 2024-03-12 Ekos Corporation Power parameters for ultrasonic catheter
US11950828B2 (en) 2021-10-20 2024-04-09 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE322230T1 (en) * 1998-09-10 2006-04-15 Percardia Inc TMR DEVICE
US6253768B1 (en) 1999-08-04 2001-07-03 Percardia, Inc. Vascular graft bypass
EP1253859B1 (en) * 2000-01-04 2009-04-15 Medtronic Vascular, Inc. Apparatus for creating a channel between adjacent body lumens
US6602286B1 (en) * 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
FR2846520B1 (en) * 2002-11-06 2006-09-29 Roquette Freres USE OF MALTODEXTRINS BRANCHED AS BLEACHES OF GRANULATION
US20090082785A1 (en) * 2007-09-24 2009-03-26 Milliman Keith L Anvil Delivery Device Accessory
WO2009075949A1 (en) * 2007-12-11 2009-06-18 Cardiac Pacemakers, Inc. Coronary vein hemodynamic sensor
WO2009111630A1 (en) * 2008-03-06 2009-09-11 Wilson-Cook Medical, Inc. Medical systems for accessing an internal bodily opening
US8818507B2 (en) * 2008-05-27 2014-08-26 Cardiac Pacemakers, Inc. Coronary vein dimensional sensor and fixation apparatus
US8945104B2 (en) * 2008-08-22 2015-02-03 Envy Medical, Inc. Microdermabrasion system with combination skin therapies
CN102448542A (en) * 2009-05-26 2012-05-09 心脏起搏器公司 System and method for rhythm identification and therapy discrimination using hemodynamic status information
JP2012528607A (en) 2009-06-01 2012-11-15 カーディアック ペースメイカーズ, インコーポレイテッド System and method for detection and treatment of decompensation based on patient hemodynamics
WO2010141284A1 (en) * 2009-06-01 2010-12-09 Cardiac Pacemakers, Inc. System and method for pacing rate control utilizing patient hemodynamic status information
US9655626B2 (en) 2014-04-28 2017-05-23 Covidien Lp Anvil assembly delivery system
CN111568507B (en) * 2020-05-15 2020-12-04 李明东 Resection device based on polyp in intestinal
WO2024019717A1 (en) * 2022-07-20 2024-01-25 Bard Peripheral Vascular, Inc. Catheters, devices, and methods for endovascular treatment of a blood vessel

Citations (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920021A (en) 1973-05-16 1975-11-18 Siegfried Hiltebrandt Coagulating devices
US3974833A (en) 1973-03-19 1976-08-17 Durden Iii John G Disposable electrosurgical cautery having optional suction control feature
US4589412A (en) 1984-01-03 1986-05-20 Intravascular Surgical Instruments, Inc. Method and apparatus for surgically removing remote deposits
US4681106A (en) 1985-08-12 1987-07-21 Intravascular Surgical Instruments, Inc. Catheter based surgical methods and apparatus therefor
US4682596A (en) * 1984-05-22 1987-07-28 Cordis Corporation Electrosurgical catheter and method for vascular applications
US4693556A (en) 1985-06-04 1987-09-15 Laser Therapeutics, Inc. Apparatus for producing a spherical pattern of light and method of manufacture
US4805616A (en) 1980-12-08 1989-02-21 Pao David S C Bipolar probes for ophthalmic surgery and methods of performing anterior capsulotomy
US4867138A (en) * 1987-05-13 1989-09-19 Olympus Optical Co., Ltd. Rigid electronic endoscope
US4886061A (en) 1988-02-09 1989-12-12 Medinnovations, Inc. Expandable pullback atherectomy catheter system
US4998933A (en) 1988-06-10 1991-03-12 Advanced Angioplasty Products, Inc. Thermal angioplasty catheter and method
US5011490A (en) 1989-12-07 1991-04-30 Medical Innovative Technologies R&D Limited Partnership Endoluminal tissue excision catheter system and method
US5078717A (en) * 1989-04-13 1992-01-07 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5100425A (en) 1989-09-14 1992-03-31 Medintec R&D Limited Partnership Expandable transluminal atherectomy catheter system and method for the treatment of arterial stenoses
US5127902A (en) 1990-09-05 1992-07-07 Medical Innovative Technologies R&D Limited Partnership Apparatus and method for precisely controlling the excision of obstructive tissue in a human blood vessel
US5129913A (en) 1990-10-04 1992-07-14 Norbert Ruppert Surgical punch apparatus
US5372603A (en) 1989-05-25 1994-12-13 Engineering And Research Associates, Inc. Hollow core coaxial catheter
US5403338A (en) 1992-01-21 1995-04-04 Scanlan International, Inc. Punch for opening passages between two compartments
US5409454A (en) 1991-02-19 1995-04-25 Arrow International Investment Corp. Apparatus for atherectomy
US5423846A (en) 1991-10-21 1995-06-13 Cathco, Inc. Dottering auger catheter system
WO1995017131A1 (en) 1993-12-22 1995-06-29 Monamed Medizintechnik Gmbh Ultrasonic marked cardiac ablation catheter
US5522834A (en) 1992-10-15 1996-06-04 Applied Medical Resources Corporation Internal mammary artery catheter and method
US5527325A (en) 1993-07-09 1996-06-18 Device For Vascular Intervention, Inc. Atherectomy catheter and method
US5556397A (en) 1994-10-26 1996-09-17 Laser Centers Of America Coaxial electrosurgical instrument
US5599345A (en) 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment apparatus
US5613972A (en) 1992-07-15 1997-03-25 The University Of Miami Surgical cutting heads with curled cutting wings
US5620439A (en) 1995-06-06 1997-04-15 George S. Abela Catheter and technique for endovascular myocardial revascularization
US5628761A (en) 1994-07-08 1997-05-13 Rizik; David G. Guide wire passage creation device
US5628762A (en) 1994-11-18 1997-05-13 Al-Tameem; Moshin Method of using a device for excision of a fistula
WO1997017100A1 (en) 1995-11-07 1997-05-15 Embol-X, Inc. Cannula with associated filter and methods of use during cardiac surgery
US5643257A (en) 1994-01-18 1997-07-01 Endovascular, Inc. Apparatus and method for venous ligation
US5643296A (en) 1994-12-16 1997-07-01 Devices For Vasclar Intervention Intravascular catheter with guiding structure
US5662671A (en) 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5665062A (en) 1995-01-23 1997-09-09 Houser; Russell A. Atherectomy catheter and RF cutting method
WO1997032532A1 (en) 1996-03-05 1997-09-12 Vnus Medical Technologies, Inc. Vascular catheter-based system for heating tissue
WO1997033522A1 (en) 1996-03-15 1997-09-18 Beth Israel Deaconess Medical Center Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo
US5672171A (en) 1994-06-30 1997-09-30 American Medical Systems, Inc. Apparatus and method for interstitial laser treatment
US5685320A (en) 1991-09-04 1997-11-11 Zimmon; David S. Lateral biopsy device
US5725521A (en) 1996-03-29 1998-03-10 Eclipse Surgical Technologies, Inc. Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications
US5725543A (en) 1993-03-11 1998-03-10 Redha; Falah Medical instrument for atherectomy
US5741270A (en) 1997-02-28 1998-04-21 Lumend, Inc. Manual actuator for a catheter system for treating a vascular occlusion
US5755697A (en) 1995-11-22 1998-05-26 Jones; Calvin E. Self-tunneling, self-securing percutaneous catheterization device and method of use thereof
WO1998025533A1 (en) 1996-12-09 1998-06-18 Scimed Life Systems, Inc. Radio frequency transmyocardial revascularization corer
US5776114A (en) 1993-07-07 1998-07-07 Devices For Vascular Intervention, Inc. Flexible housing for intracorporeal use
US5800378A (en) * 1992-08-12 1998-09-01 Vidamed, Inc. Medical probe device and method
WO1998038941A1 (en) 1997-03-06 1998-09-11 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
WO1998038939A1 (en) 1997-03-06 1998-09-11 Scimed Life Systems, Inc. Percutaneous bypass with branching vessel
WO1998038942A1 (en) 1997-03-06 1998-09-11 Scimed Life Systems, Inc. Percutaneous bypass by tunneling through vessel wall
US5827315A (en) 1994-01-04 1998-10-27 Yoon; Inbae Safety penetrating instrument with penetrating member protected after penetration to predetermined depth
US5827324A (en) 1997-03-06 1998-10-27 Scimed Life Systems, Inc. Distal protection device
US5843019A (en) 1992-01-07 1998-12-01 Arthrocare Corporation Shaped electrodes and methods for electrosurgical cutting and ablation
US5843103A (en) 1997-03-06 1998-12-01 Scimed Life Systems, Inc. Shaped wire rotational atherectomy device
WO1999001074A1 (en) 1997-07-03 1999-01-14 Neothermia Corporation Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue
US5957900A (en) * 1996-07-10 1999-09-28 Asahi Kogaku Kogyo Kabushiki Kaisha Treatment accessory for endoscope
US6047700A (en) * 1998-03-30 2000-04-11 Arthrocare Corporation Systems and methods for electrosurgical removal of calcified deposits

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018228A (en) * 1975-02-24 1977-04-19 Goosen Carl C Surgical punch apparatus
US4926858A (en) * 1984-05-30 1990-05-22 Devices For Vascular Intervention, Inc. Atherectomy device for severe occlusions
EP0229782B1 (en) * 1985-06-14 1992-11-04 Bristol-Myers Squibb Company Methods for identifying alleles associated with increased risk of diabetes
DE68925757T2 (en) * 1988-06-13 1996-09-05 Samuel Shiber Atherectomy system with a guidewire
JPH02143202A (en) * 1988-11-25 1990-06-01 Takashi Mori Optical radiator
AU5422490A (en) * 1989-04-18 1990-11-16 Derma-Lase Limited Method and apparatus for the removal of tattoos
US4993412A (en) * 1989-08-02 1991-02-19 Eclipse Surgical Technologies, Inc. Method and apparatus for removal of obstructive substance from body channels
US5261904A (en) * 1990-01-30 1993-11-16 C. R. Bard, Inc. Laser catheter having diffraction grating for beam shaping
US5409453A (en) * 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
FR2675388B1 (en) * 1991-04-22 1993-07-30 Boussignac Georges CATHETER FOR INTRODUCTION INTO A BODY CHANNEL.
US5292320A (en) * 1992-07-06 1994-03-08 Ceramoptec, Inc. Radial medical laser delivery device
US5556377A (en) * 1992-08-12 1996-09-17 Vidamed, Inc. Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe
US5396887A (en) * 1993-09-23 1995-03-14 Cardiac Pathways Corporation Apparatus and method for detecting contact pressure
US5735844A (en) * 1995-02-01 1998-04-07 The General Hospital Corporation Hair removal using optical pulses
CA2234389A1 (en) * 1995-10-13 1997-04-17 Transvascular, Inc. A device, system and method for interstitial transvascular intervention
ATE275880T1 (en) * 1995-10-13 2004-10-15 Transvascular Inc DEVICE FOR BYPASSING ARTERIAL Narrowings AND/OR FOR PERFORMING OTHER TRANSVASCULAR PROCEDURES
JP2001508318A (en) * 1996-02-02 2001-06-26 トランスバスキュラー インコーポレイテッド Apparatus, systems and methods for interstitial transvascular intervention
US5738680A (en) * 1996-04-05 1998-04-14 Eclipse Surgical Technologies, Inc. Laser device with piercing tip for transmyocardial revascularization procedures

Patent Citations (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974833A (en) 1973-03-19 1976-08-17 Durden Iii John G Disposable electrosurgical cautery having optional suction control feature
US3920021A (en) 1973-05-16 1975-11-18 Siegfried Hiltebrandt Coagulating devices
US4805616A (en) 1980-12-08 1989-02-21 Pao David S C Bipolar probes for ophthalmic surgery and methods of performing anterior capsulotomy
US4589412A (en) 1984-01-03 1986-05-20 Intravascular Surgical Instruments, Inc. Method and apparatus for surgically removing remote deposits
US4682596A (en) * 1984-05-22 1987-07-28 Cordis Corporation Electrosurgical catheter and method for vascular applications
US4693556A (en) 1985-06-04 1987-09-15 Laser Therapeutics, Inc. Apparatus for producing a spherical pattern of light and method of manufacture
US4681106A (en) 1985-08-12 1987-07-21 Intravascular Surgical Instruments, Inc. Catheter based surgical methods and apparatus therefor
US4867138A (en) * 1987-05-13 1989-09-19 Olympus Optical Co., Ltd. Rigid electronic endoscope
US4886061A (en) 1988-02-09 1989-12-12 Medinnovations, Inc. Expandable pullback atherectomy catheter system
US4998933A (en) 1988-06-10 1991-03-12 Advanced Angioplasty Products, Inc. Thermal angioplasty catheter and method
US5078717A (en) * 1989-04-13 1992-01-07 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5372603A (en) 1989-05-25 1994-12-13 Engineering And Research Associates, Inc. Hollow core coaxial catheter
US5100425A (en) 1989-09-14 1992-03-31 Medintec R&D Limited Partnership Expandable transluminal atherectomy catheter system and method for the treatment of arterial stenoses
US5011490A (en) 1989-12-07 1991-04-30 Medical Innovative Technologies R&D Limited Partnership Endoluminal tissue excision catheter system and method
US5127902A (en) 1990-09-05 1992-07-07 Medical Innovative Technologies R&D Limited Partnership Apparatus and method for precisely controlling the excision of obstructive tissue in a human blood vessel
US5129913A (en) 1990-10-04 1992-07-14 Norbert Ruppert Surgical punch apparatus
US5409454A (en) 1991-02-19 1995-04-25 Arrow International Investment Corp. Apparatus for atherectomy
US5685320A (en) 1991-09-04 1997-11-11 Zimmon; David S. Lateral biopsy device
US5423846A (en) 1991-10-21 1995-06-13 Cathco, Inc. Dottering auger catheter system
US5843019A (en) 1992-01-07 1998-12-01 Arthrocare Corporation Shaped electrodes and methods for electrosurgical cutting and ablation
US5403338A (en) 1992-01-21 1995-04-04 Scanlan International, Inc. Punch for opening passages between two compartments
US5613972A (en) 1992-07-15 1997-03-25 The University Of Miami Surgical cutting heads with curled cutting wings
US5800378A (en) * 1992-08-12 1998-09-01 Vidamed, Inc. Medical probe device and method
US5522834A (en) 1992-10-15 1996-06-04 Applied Medical Resources Corporation Internal mammary artery catheter and method
US5725543A (en) 1993-03-11 1998-03-10 Redha; Falah Medical instrument for atherectomy
US5776114A (en) 1993-07-07 1998-07-07 Devices For Vascular Intervention, Inc. Flexible housing for intracorporeal use
US5527325A (en) 1993-07-09 1996-06-18 Device For Vascular Intervention, Inc. Atherectomy catheter and method
US5599345A (en) 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment apparatus
WO1995017131A1 (en) 1993-12-22 1995-06-29 Monamed Medizintechnik Gmbh Ultrasonic marked cardiac ablation catheter
US5827315A (en) 1994-01-04 1998-10-27 Yoon; Inbae Safety penetrating instrument with penetrating member protected after penetration to predetermined depth
US5643257A (en) 1994-01-18 1997-07-01 Endovascular, Inc. Apparatus and method for venous ligation
US5672171A (en) 1994-06-30 1997-09-30 American Medical Systems, Inc. Apparatus and method for interstitial laser treatment
US5628761A (en) 1994-07-08 1997-05-13 Rizik; David G. Guide wire passage creation device
US5556397A (en) 1994-10-26 1996-09-17 Laser Centers Of America Coaxial electrosurgical instrument
US5628762A (en) 1994-11-18 1997-05-13 Al-Tameem; Moshin Method of using a device for excision of a fistula
US5643296A (en) 1994-12-16 1997-07-01 Devices For Vasclar Intervention Intravascular catheter with guiding structure
US5665062A (en) 1995-01-23 1997-09-09 Houser; Russell A. Atherectomy catheter and RF cutting method
US5620439A (en) 1995-06-06 1997-04-15 George S. Abela Catheter and technique for endovascular myocardial revascularization
WO1997017100A1 (en) 1995-11-07 1997-05-15 Embol-X, Inc. Cannula with associated filter and methods of use during cardiac surgery
US5755697A (en) 1995-11-22 1998-05-26 Jones; Calvin E. Self-tunneling, self-securing percutaneous catheterization device and method of use thereof
WO1997032532A1 (en) 1996-03-05 1997-09-12 Vnus Medical Technologies, Inc. Vascular catheter-based system for heating tissue
WO1997033522A1 (en) 1996-03-15 1997-09-18 Beth Israel Deaconess Medical Center Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo
US5725521A (en) 1996-03-29 1998-03-10 Eclipse Surgical Technologies, Inc. Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications
US5957900A (en) * 1996-07-10 1999-09-28 Asahi Kogaku Kogyo Kabushiki Kaisha Treatment accessory for endoscope
US5662671A (en) 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
WO1998025533A1 (en) 1996-12-09 1998-06-18 Scimed Life Systems, Inc. Radio frequency transmyocardial revascularization corer
US5741270A (en) 1997-02-28 1998-04-21 Lumend, Inc. Manual actuator for a catheter system for treating a vascular occlusion
WO1998038939A1 (en) 1997-03-06 1998-09-11 Scimed Life Systems, Inc. Percutaneous bypass with branching vessel
US5827324A (en) 1997-03-06 1998-10-27 Scimed Life Systems, Inc. Distal protection device
WO1998038942A1 (en) 1997-03-06 1998-09-11 Scimed Life Systems, Inc. Percutaneous bypass by tunneling through vessel wall
US5843103A (en) 1997-03-06 1998-12-01 Scimed Life Systems, Inc. Shaped wire rotational atherectomy device
WO1998038941A1 (en) 1997-03-06 1998-09-11 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
WO1999001074A1 (en) 1997-07-03 1999-01-14 Neothermia Corporation Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue
US6047700A (en) * 1998-03-30 2000-04-11 Arthrocare Corporation Systems and methods for electrosurgical removal of calcified deposits

Cited By (276)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8353908B2 (en) * 1996-09-20 2013-01-15 Novasys Medical, Inc. Treatment of tissue in sphincters, sinuses, and orifices
US20100168733A1 (en) * 1996-09-20 2010-07-01 Novasys Medical, Inc. Treatment of tissue in sphincters, sinuses, and orifices
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
US20030120195A1 (en) * 1998-01-13 2003-06-26 Lumend, Inc. Re-entry catheter
US6719725B2 (en) 1998-01-13 2004-04-13 Lumend, Inc. Re-entry catheter
US20100174302A1 (en) * 1998-04-10 2010-07-08 Ev3 Endovascular, Inc. Rotational atherectomy system and methods of use
US7413556B2 (en) * 1998-06-29 2008-08-19 Ekos Corporation Sheath for use with an ultrasound element
US20040015122A1 (en) * 1998-06-29 2004-01-22 John Zhang Sheath for use with an ultrasound element
US20070112268A1 (en) * 1998-06-29 2007-05-17 John Zhang Sheath for use with an ultrasound element
US8764700B2 (en) 1998-06-29 2014-07-01 Ekos Corporation Sheath for use with an ultrasound element
US20030216681A1 (en) * 1998-06-29 2003-11-20 John Zhang Sheath for use with an ultrasound element
US20040077988A1 (en) * 1998-08-27 2004-04-22 Heartstent Corporation Healing transmyocardial implant
US20030105514A1 (en) * 1998-09-10 2003-06-05 Percardia, Inc. Designs for left ventricular conduit
US20020058897A1 (en) * 1998-09-10 2002-05-16 Percardia, Inc. Designs for left ventricular conduit
US6694983B2 (en) 1998-09-10 2004-02-24 Percardia, Inc. Delivery methods for left ventricular conduit
US8216174B2 (en) 1998-09-10 2012-07-10 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US7736327B2 (en) 1998-09-10 2010-06-15 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8597226B2 (en) 1998-09-10 2013-12-03 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8597315B2 (en) 1999-08-19 2013-12-03 Covidien Lp Atherectomy catheter with first and second imaging devices
US9486237B2 (en) 1999-08-19 2016-11-08 Covidien Lp Methods and devices for cutting tissue
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US8998937B2 (en) 1999-08-19 2015-04-07 Covidien Lp Methods and devices for cutting tissue
US10022145B2 (en) 1999-08-19 2018-07-17 Covidien Lp Methods and devices for cutting tissue
US9532799B2 (en) 1999-08-19 2017-01-03 Covidien Lp Method and devices for cutting tissue
US8911459B2 (en) 1999-08-19 2014-12-16 Covidien Lp Debulking catheters and methods
US9615850B2 (en) 1999-08-19 2017-04-11 Covidien Lp Atherectomy catheter with aligned imager
US9788854B2 (en) 1999-08-19 2017-10-17 Covidien Lp Debulking catheters and methods
US20030137008A1 (en) * 2000-03-28 2003-07-24 Hidetoshi Nozaki Solid state imaging device having a photodiode and a MOSFET and method of manufacturing the same
US20020045928A1 (en) * 2000-05-04 2002-04-18 Percardia, Inc. Methods and devices for delivering a ventricular stent
US8968284B2 (en) 2000-10-02 2015-03-03 Verathon Inc. Apparatus and methods for treating female urinary incontinence
US9241733B2 (en) 2000-12-20 2016-01-26 Covidien Lp Debulking catheter
US8226674B2 (en) 2000-12-20 2012-07-24 Tyco Healthcare Group Lp Debulking catheters and methods
US8469979B2 (en) 2000-12-20 2013-06-25 Covidien Lp High capacity debulking catheter with distal driven cutting wheel
US9415242B2 (en) 2001-12-03 2016-08-16 Ekos Corporation Catheter with multiple ultrasound radiating members
US10926074B2 (en) 2001-12-03 2021-02-23 Ekos Corporation Catheter with multiple ultrasound radiating members
US10080878B2 (en) 2001-12-03 2018-09-25 Ekos Corporation Catheter with multiple ultrasound radiating members
US7727178B2 (en) 2001-12-03 2010-06-01 Ekos Corporation Catheter with multiple ultrasound radiating members
US8696612B2 (en) 2001-12-03 2014-04-15 Ekos Corporation Catheter with multiple ultrasound radiating members
US8167831B2 (en) 2001-12-03 2012-05-01 Ekos Corporation Catheter with multiple ultrasound radiating members
US7828762B2 (en) 2001-12-03 2010-11-09 Ekos Corporation Catheter with multiple ultrasound radiating members
US20060106308A1 (en) * 2001-12-14 2006-05-18 Hansmann Douglas R Blood flow reestablishment determination
US8852166B1 (en) 2002-04-01 2014-10-07 Ekos Corporation Ultrasonic catheter power control
US9943675B1 (en) 2002-04-01 2018-04-17 Ekos Corporation Ultrasonic catheter power control
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US9782562B2 (en) 2002-04-04 2017-10-10 Angiodynamics, Inc. Venous insufficiency treatment method
US20040015193A1 (en) * 2002-04-11 2004-01-22 Transvascular, Inc. Devices and methods for transluminal or transthoracic interstitial electrode placement
US7191015B2 (en) 2002-04-11 2007-03-13 Medtronic Vascular, Inc. Devices and methods for transluminal or transthoracic interstitial electrode placement
US8295947B2 (en) 2002-04-11 2012-10-23 Medtronic Vascular, Inc. Devices and methods for transluminal or transthoracic interstitial electrode placement
US20070100410A1 (en) * 2002-04-11 2007-05-03 Medtronic Vascular, Inc. Devices and methods for transluminal or transthoracic interstitial electrode placement
US20080015559A1 (en) * 2002-07-10 2008-01-17 Appling William M Endovascular treatment device having a fiber tip spacer
US8864755B2 (en) 2002-07-10 2014-10-21 Angiodynamics, Inc. Device and method for endovascular treatment for causing closure of a blood vessel
US7559329B2 (en) 2002-07-10 2009-07-14 Angiodynamics, Inc. Method of treating a blood vessel with an optical fiber having a spacer
US10238453B2 (en) 2002-07-10 2019-03-26 Angiodynamics, Inc. Method of making an endovascular laser treatment device for causing closure of a blood vessel
US7273478B2 (en) * 2002-07-10 2007-09-25 Angiodynamics, Inc. Endovascular treatment device having a fiber tip spacer
US20090264875A1 (en) * 2002-07-10 2009-10-22 Appling William M Method of Treating a Blood Vessel with an Optical Fiber Having a Spacer
US8425501B2 (en) 2002-07-10 2013-04-23 Angiodynamics, Inc. Method of treating a blood vessel with an optical fiber having a spacer
US20080188843A1 (en) * 2002-07-10 2008-08-07 Appling William M Device and method for endovascular treatment for causing closure of a blood vessel
US20040010248A1 (en) * 2002-07-10 2004-01-15 Appling William M. Endovascular treatment device having a fiber tip spacer
US8840606B2 (en) 2002-07-10 2014-09-23 Angiodynamics, Inc. Method of treating a blood vessel with an optical fiber having a spacer
US20080287939A1 (en) * 2002-07-10 2008-11-20 Appling William M Endovascular thermal treatment device with flexible guide tip and method
US8864754B2 (en) 2002-07-10 2014-10-21 Angiodynamics, Inc. Device and method for endovascular treatment for causing closure of a blood vessel
US20080208180A1 (en) * 2002-07-10 2008-08-28 Cartier William A Endovascular treatment sheath having a heat insulative tip and method for using the same
US20040049171A1 (en) * 2002-09-09 2004-03-11 Heartstent Corporation Device for placing transmyocardial implant
US20040199228A1 (en) * 2003-01-03 2004-10-07 Wilson Richard R. Ultrasonic catheter with axial energy field
US20110060253A1 (en) * 2003-01-03 2011-03-10 Ekos Corporation Ultrasonic catheter with axial energy field
US7771372B2 (en) 2003-01-03 2010-08-10 Ekos Corporation Ultrasonic catheter with axial energy field
US20040133969A1 (en) * 2003-01-10 2004-07-15 Tyler Pipe Company, A Division Of Ransom Industries, Lp Closet carrier system and method of assembly
US20060241342A1 (en) * 2003-03-13 2006-10-26 Medtronic Transvascular, Inc. Optically guided penetration catheters and their methods of use
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
US9999438B2 (en) 2003-04-22 2018-06-19 Covidien Lp Methods and devices for cutting tissue at a vascular location
US8961546B2 (en) 2003-04-22 2015-02-24 Covidien Lp Methods and devices for cutting tissue at a vascular location
US20050215946A1 (en) * 2004-01-29 2005-09-29 Hansmann Douglas R Method and apparatus for detecting vascular conditions with a catheter
US9107590B2 (en) 2004-01-29 2015-08-18 Ekos Corporation Method and apparatus for detecting vascular conditions with a catheter
US20050209578A1 (en) * 2004-01-29 2005-09-22 Christian Evans Edward A Ultrasonic catheter with segmented fluid delivery
US20070161951A1 (en) * 2004-01-29 2007-07-12 Ekos Corporation Treatment of vascular occlusions using elevated temperatures
US20050278013A1 (en) * 2004-05-26 2005-12-15 Matthew Rust Method for endovascular bypass stent graft delivery
US20070203565A1 (en) * 2004-05-26 2007-08-30 Matthew Rust Method for Endovascular Bypass Stent Graft Delivery
US7815656B2 (en) 2004-05-26 2010-10-19 Medtronic Vascular, Inc. Method for endovascular bypass stent graft delivery
US20080194939A1 (en) * 2004-09-08 2008-08-14 Advotek Medical Devices Ltd. Minimally Invasive Surgical Appartus and Methods
US11446170B2 (en) 2004-09-08 2022-09-20 Limflow Gmbh Minimally invasive surgical apparatus and methods
US10398580B2 (en) 2004-09-08 2019-09-03 Limflow Gmbh Minimally invasive surgical apparatus and methods
US20060111704A1 (en) * 2004-11-22 2006-05-25 Rox Medical, Inc. Devices, systems, and methods for energy assisted arterio-venous fistula creation
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US20070032808A1 (en) * 2005-08-03 2007-02-08 Azam Anwar System and method for addressing total occlusion in a vascular environment
US11793978B2 (en) 2005-09-12 2023-10-24 Boston Scientific Scimed, Inc. Endovascular devices and methods
US11229776B2 (en) 2005-09-12 2022-01-25 Bridgepoint Medical, Inc. Endovascular devices and methods
US10806487B2 (en) 2005-09-12 2020-10-20 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US10342569B2 (en) 2005-09-12 2019-07-09 Bridgeport Medical, Inc. Endovascular devices and methods
US11076882B2 (en) 2005-09-12 2021-08-03 Bridgepoint Medical, Inc. Endovascular devices and methods
US9788855B2 (en) 2005-09-12 2017-10-17 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US8636712B2 (en) 2005-09-12 2014-01-28 Bridgepoint Medical, Inc. Endovascular devices and methods
US7918870B2 (en) 2005-09-12 2011-04-05 Bridgepoint Medical, Inc. Endovascular devices and methods
US10143487B2 (en) 2005-09-12 2018-12-04 Bridgepoint Medical, Inc. Endovascular devices and methods
US20070093782A1 (en) * 2005-09-12 2007-04-26 Kugler Chad J Endovascular devices and methods
US10166035B2 (en) 2005-09-12 2019-01-01 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US9308019B2 (en) 2005-09-12 2016-04-12 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US10315010B2 (en) 2005-09-12 2019-06-11 Bridgepoint Medical, Inc. Endovascular devices and methods
US20070093781A1 (en) * 2005-09-12 2007-04-26 Kugler Chad J Endovascular devices and methods for exploiting intramural space
US9237897B2 (en) 2005-09-12 2016-01-19 Bridgepoint Medical, Inc. Endovascular devices and methods
US8323261B2 (en) 2005-09-12 2012-12-04 Bridgepoint Medical, Inc. Methods of accessing an intramural space
US20070093783A1 (en) * 2005-09-12 2007-04-26 Kugler Chad J Endovascular devices and methods
US11607245B2 (en) 2005-09-12 2023-03-21 Boston Scientific Scimed, Inc. Endovascular devices and methods for exploiting intramural space
US11020141B2 (en) 2005-09-12 2021-06-01 Bridgepoint Medical, Inc. Endovascular devices and methods
US8512310B2 (en) 2005-09-12 2013-08-20 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US8961494B2 (en) 2005-09-12 2015-02-24 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US20070093780A1 (en) * 2005-09-12 2007-04-26 Kugler Chad J Endovascular devices and methods for exploiting intramural space
US8083727B2 (en) 2005-09-12 2011-12-27 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US20070093779A1 (en) * 2005-09-12 2007-04-26 Kugler Chad J Endovascular devices and methods
US7938819B2 (en) 2005-09-12 2011-05-10 Bridgepoint Medical, Inc. Endovascular devices and methods
US11779361B2 (en) 2005-09-12 2023-10-10 Boston Scientific Scimed, Inc. Endovascular devices and methods for exploiting intramural space
US10939928B2 (en) 2005-09-12 2021-03-09 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US8025655B2 (en) 2005-09-12 2011-09-27 Bridgepoint Medical, Inc. Endovascular devices and methods
US11826070B2 (en) 2005-09-12 2023-11-28 Boston Scientific Scimed, Inc. Endovascular devices and methods
US20070255303A1 (en) * 2006-05-01 2007-11-01 Ethicon Endo-Surgery, Inc. Integrated Guidewire Needle Knife Device
US11666355B2 (en) 2006-05-26 2023-06-06 Covidien Lp Catheter including cutting element and energy emitting element
US10588653B2 (en) 2006-05-26 2020-03-17 Covidien Lp Catheter including cutting element and energy emitting element
US9801647B2 (en) 2006-05-26 2017-10-31 Covidien Lp Catheter including cutting element and energy emitting element
US8192363B2 (en) 2006-10-27 2012-06-05 Ekos Corporation Catheter with multiple ultrasound radiating members
US9060802B2 (en) 2006-11-21 2015-06-23 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US10537716B2 (en) 2006-11-21 2020-01-21 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US11298511B2 (en) 2006-11-21 2022-04-12 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US9717889B2 (en) 2006-11-21 2017-08-01 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US10888354B2 (en) 2006-11-21 2021-01-12 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US11925367B2 (en) 2007-01-08 2024-03-12 Ekos Corporation Power parameters for ultrasonic catheter
US7780691B2 (en) 2007-03-21 2010-08-24 Ethicon Endo-Surgery, Inc. Endoscopic tissue resection device
US20080234693A1 (en) * 2007-03-21 2008-09-25 Ethicon Endo-Surgery, Inc. Endoscopic Tissue Resection Device
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11672553B2 (en) 2007-06-22 2023-06-13 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
US8632556B2 (en) 2007-10-22 2014-01-21 Bridgepoint Medical, Inc. Methods and devices for crossing chronic total occlusions
US10448940B2 (en) 2007-10-22 2019-10-22 Bridgepoint Medical, Inc. Methods and devices for crossing chronic total occlusions
US11510663B2 (en) 2007-10-22 2022-11-29 Boston Scientific Scimed, Inc. Methods and devices for crossing chronic total occlusions
US20090124899A1 (en) * 2007-10-22 2009-05-14 Peter Alan Jacobs Methods and devices for crossing chronic total occlusions
US20090118673A1 (en) * 2007-11-07 2009-05-07 Jerett Creed Needle injection catheter
US11540857B2 (en) 2008-02-05 2023-01-03 Boston Scientific Scimed, Inc. Endovascular device with a tissue piercing distal probe and associated methods
US9872685B2 (en) 2008-02-05 2018-01-23 Bridgepoint Medical, Inc. Crossing occlusions in blood vessels
US8202246B2 (en) 2008-02-05 2012-06-19 Bridgepoint Medical, Inc. Crossing occlusions in blood vessels
US8337425B2 (en) 2008-02-05 2012-12-25 Bridgepoint Medical, Inc. Endovascular device with a tissue piercing distal probe and associated methods
US11065002B2 (en) 2008-02-05 2021-07-20 Bridgepoint Medical, Inc. Crossing occlusions in blood vessels
US10575869B2 (en) 2008-02-05 2020-03-03 Bridgepoint Medical, Inc. Endovascular device with a tissue piercing distal probe and associated methods
US9445834B2 (en) 2008-02-25 2016-09-20 Covidien Lp Methods and devices for cutting tissue
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
US10219824B2 (en) 2008-02-25 2019-03-05 Covidien Lp Methods and devices for cutting tissue
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US20090248049A1 (en) * 2008-03-25 2009-10-01 Medtronic Vascular, Inc. Methods for Treating Vulnerable Plaque
US8016842B2 (en) 2008-03-25 2011-09-13 Medtronic Vascular, Inc. Methods for treating vulnerable plaque
US20090254105A1 (en) * 2008-04-04 2009-10-08 Medtronic Vascular, Inc. Anastomotic connectors
US20090259174A1 (en) * 2008-04-15 2009-10-15 Medtronic Vascular, Inc. Methods and devices for treating vulnerable atherosclerotic plaque
US20090270890A1 (en) * 2008-04-28 2009-10-29 David Bryan Robinson Methods and apparatus for crossing occlusions in blood vessels
US8709028B2 (en) 2008-04-28 2014-04-29 Bridgepoint Medical, Inc. Methods and appartus for crossing occlusions in blood vessels
US9005225B2 (en) 2008-04-28 2015-04-14 Bridgepoint Medical, Inc. Methods and appartus for crossing occlusions in blood vessels
US8496679B2 (en) 2008-04-28 2013-07-30 Bridgepoint Medical, Inc. Methods and apparatus for crossing occlusions in blood vessels
US8172863B2 (en) 2008-04-28 2012-05-08 Bridgepoint Medical, Inc. Methods and apparatus for crossing occlusions in blood vessels
US20100130835A1 (en) * 2008-09-30 2010-05-27 Rox Medical, Inc. Methods for screening and treating patients with compromised cardiopulmonary function
US8414604B2 (en) 2008-10-13 2013-04-09 Covidien Lp Devices and methods for manipulating a catheter shaft
US10507037B2 (en) 2008-10-13 2019-12-17 Covidien Lp Method for manipulating catheter shaft
US9192406B2 (en) 2008-10-13 2015-11-24 Covidien Lp Method for manipulating catheter shaft
US9199067B2 (en) 2009-01-29 2015-12-01 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US9737697B2 (en) 2009-01-29 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US10112036B2 (en) 2009-01-29 2018-10-30 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
NL2002597C2 (en) * 2009-03-06 2010-09-07 Tobrix B V Endovascular treatment device, system for endovascular treatment and method of operating
WO2010101464A1 (en) * 2009-03-06 2010-09-10 Tobrix B.V. Endovascular treatment device, system for endovascular treatment and method of operating (the same)
US10555753B2 (en) 2009-04-29 2020-02-11 Covidien Lp Methods and devices for cutting and abrading tissue
US9687266B2 (en) 2009-04-29 2017-06-27 Covidien Lp Methods and devices for cutting and abrading tissue
US8192452B2 (en) 2009-05-14 2012-06-05 Tyco Healthcare Group Lp Easily cleaned atherectomy catheters and methods of use
US8574249B2 (en) 2009-05-14 2013-11-05 Covidien Lp Easily cleaned atherectomy catheters and methods of use
US9220530B2 (en) 2009-05-14 2015-12-29 Covidien Lp Easily cleaned atherectomy catheters and methods of use
US9687267B2 (en) 2009-12-02 2017-06-27 Covidien Lp Device for cutting tissue
US10499947B2 (en) 2009-12-02 2019-12-10 Covidien Lp Device for cutting tissue
US8496677B2 (en) 2009-12-02 2013-07-30 Covidien Lp Methods and devices for cutting tissue
US9028512B2 (en) 2009-12-11 2015-05-12 Covidien Lp Material removal device having improved material capture efficiency and methods of use
US10751082B2 (en) 2009-12-11 2020-08-25 Covidien Lp Material removal device having improved material capture efficiency and methods of use
US9913659B2 (en) 2009-12-11 2018-03-13 Covidien Lp Material removal device having improved material capture efficiency and methods of use
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US9119662B2 (en) 2010-06-14 2015-09-01 Covidien Lp Material removal device and method of use
US9855072B2 (en) 2010-06-14 2018-01-02 Covidien Lp Material removal device and method of use
US9439728B2 (en) 2010-06-15 2016-09-13 Avenu Medical, Inc. Systems for creating arteriovenous (AV) fistulas
EP2582314A4 (en) * 2010-06-15 2017-08-02 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US11690944B2 (en) 2010-06-15 2023-07-04 Avenu Medical, Inc. Systems and methods for creating arteriovenous (AV) fistulas
US10751461B2 (en) 2010-06-15 2020-08-25 Avenu Medical, Inc. Systems and methods for creating arteriovenous (AV) fistulas
US9931164B2 (en) 2010-06-15 2018-04-03 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US11083518B2 (en) 2010-06-15 2021-08-10 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter and methods
US9452015B2 (en) 2010-06-15 2016-09-27 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US9445868B2 (en) 2010-06-15 2016-09-20 Avenu Medical, Inc. Systems and methods for creating arteriovenous (AV) fistulas
US9717520B2 (en) 2010-10-28 2017-08-01 Covidien Lp Material removal device and method of use
US8920450B2 (en) 2010-10-28 2014-12-30 Covidien Lp Material removal device and method of use
US10952762B2 (en) 2010-10-28 2021-03-23 Covidien Lp Material removal device and method of use
US8808186B2 (en) 2010-11-11 2014-08-19 Covidien Lp Flexible debulking catheters with imaging and methods of use and manufacture
US9326789B2 (en) 2010-11-11 2016-05-03 Covidien Lp Flexible debulking catheters with imaging and methods of use and manufacture
US11576724B2 (en) 2011-02-24 2023-02-14 Eximo Medical Ltd. Hybrid catheter for vascular intervention
US9138230B1 (en) 2011-04-29 2015-09-22 Avenu Medical, Inc. Systems and methods for creating arteriovenous (AV) fistulas
US9649157B1 (en) 2011-04-29 2017-05-16 Avenu Medical, Inc. Systems and methods for creating arteriovenous (AV) fistulas
US9955972B1 (en) 2011-04-29 2018-05-01 Avenu Medical, Inc. Systems and methods for creating arteriovenous (AV) fistulas
US11458290B2 (en) 2011-05-11 2022-10-04 Ekos Corporation Ultrasound system
US9814513B2 (en) 2011-06-30 2017-11-14 Angiodynamics, Inc. Endovascular plasma treatment device and method of use
US8992717B2 (en) 2011-09-01 2015-03-31 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US9770259B2 (en) 2011-09-01 2017-09-26 Covidien Lp Catheter with helical drive shaft and methods of manufacture
US10335188B2 (en) 2011-09-01 2019-07-02 Covidien Lp Methods of manufacture of catheter with helical drive shaft
US8951276B2 (en) 2011-11-04 2015-02-10 Avenu Medical, Inc. Systems and methods for percutaneous intravascular access and guidewire placement
US9801653B2 (en) 2011-11-04 2017-10-31 Avenu Medical, Inc. Systems and methods for percutaneous intravascular access and guidewire placement
US9522016B2 (en) 2011-11-04 2016-12-20 Avenu Medical, Inc. Systems and methods for percutaneous intravascular access and guidewire placement
US10231771B2 (en) 2012-02-08 2019-03-19 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US9474562B2 (en) 2012-02-08 2016-10-25 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US11172976B2 (en) 2012-02-08 2021-11-16 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US9579157B2 (en) 2012-09-13 2017-02-28 Covidien Lp Cleaning device for medical instrument and method of use
US9532844B2 (en) 2012-09-13 2017-01-03 Covidien Lp Cleaning device for medical instrument and method of use
US10406316B2 (en) 2012-09-13 2019-09-10 Covidien Lp Cleaning device for medical instrument and method of use
US10434281B2 (en) 2012-09-13 2019-10-08 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
US10932811B2 (en) 2012-11-08 2021-03-02 Covidien Lp Tissue-removing catheter with rotatable cutter
US11457970B2 (en) 2012-11-14 2022-10-04 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US9439710B2 (en) 2012-11-14 2016-09-13 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US10722285B2 (en) 2012-11-14 2020-07-28 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter
US10786661B2 (en) 2013-03-13 2020-09-29 The Spectranetics Corporation Apparatus and method for balloon angioplasty
US10201387B2 (en) 2013-03-13 2019-02-12 The Spectranetics Corporation Laser-induced fluid filled balloon catheter
US10842567B2 (en) 2013-03-13 2020-11-24 The Spectranetics Corporation Laser-induced fluid filled balloon catheter
US9320530B2 (en) 2013-03-13 2016-04-26 The Spectranetics Corporation Assisted cutting balloon
US11653923B1 (en) 2013-08-01 2023-05-23 Avenu Medical, Inc. Percutaneous arterial to venous anastomosis clip application catheter system and methods
US10695065B1 (en) 2013-08-01 2020-06-30 Avenu Medical, Inc. Percutaneous arterial to venous anastomosis clip application catheter system and methods
US10070866B1 (en) 2013-08-01 2018-09-11 Avenu Medical, Inc. Percutaneous arterial to venous anastomosis clip application catheter system and methods
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US10596357B2 (en) 2014-01-15 2020-03-24 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US11278708B2 (en) 2014-01-15 2022-03-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US9737696B2 (en) 2014-01-15 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US10772672B2 (en) 2014-03-06 2020-09-15 Avenu Medical, Inc. Systems and methods for percutaneous access and formation of arteriovenous fistulas
US11877785B2 (en) 2014-03-06 2024-01-23 Avenu Medical, Inc. Systems and methods for percutaneous access and formation of arteriovenous fistulas
US10596356B2 (en) 2014-06-19 2020-03-24 Limflow Gmbh Methods for placing a stent-graft to cover collateral vessels in lower extremity vasculature
US9545263B2 (en) 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
US10213224B2 (en) 2014-06-27 2019-02-26 Covidien Lp Cleaning device for catheter and catheter including the same
US11246659B2 (en) 2014-08-25 2022-02-15 The Spectranetics Corporation Liquid laser-induced pressure wave emitting catheter sheath
US10092742B2 (en) 2014-09-22 2018-10-09 Ekos Corporation Catheter system
US10507320B2 (en) 2014-09-22 2019-12-17 Ekos Corporation Catheter system
US9669195B2 (en) 2014-10-31 2017-06-06 Cerevasc, Llc Methods and systems for treating hydrocephalus
US9545505B2 (en) 2014-10-31 2017-01-17 Cerevasc, Llc Methods and systems for treating hydrocephalus
US10058686B2 (en) 2014-10-31 2018-08-28 Cerevasc, Llc Methods and systems for treating hydrocephalus
US9662479B2 (en) 2014-10-31 2017-05-30 Cerevasc, Llc Methods and systems for treating hydrocephalus
US9724501B2 (en) 2014-10-31 2017-08-08 Cerevasc, Llc Methods and systems for treating hydrocephalus
US10765846B2 (en) 2014-10-31 2020-09-08 CereVasc, Inc. Methods and systems for draining cerebrospinal fluid into the venous system
US10307576B2 (en) 2014-10-31 2019-06-04 Cerevasc, Llc Systems and methods for deploying an implant in the vasculature
US9387311B1 (en) 2014-10-31 2016-07-12 Cerevasc, Llc Methods and systems for treating hydrocephalus
US10279154B2 (en) 2014-10-31 2019-05-07 Cerevasc, Llc Methods and systems for treating hydrocephalus
US10850078B2 (en) 2014-12-30 2020-12-01 The Spectranetics Corporation Electrically-induced fluid filled balloon catheter
US10898213B2 (en) 2014-12-30 2021-01-26 The Spectranetics Corporation Electrically-induced pressure wave emitting catheter sheath
US11058492B2 (en) 2014-12-30 2021-07-13 The Spectranetics Corporation Laser-induced pressure wave emitting catheter sheath
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11740138B2 (en) 2015-06-10 2023-08-29 Ekos Corporation Ultrasound catheter
US10656025B2 (en) 2015-06-10 2020-05-19 Ekos Corporation Ultrasound catheter
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US11918224B2 (en) 2015-08-21 2024-03-05 Avenu Medical, Inc. Systems and methods for percutaneous access and formation of arteriovenous fistulas
US11166727B2 (en) 2015-08-21 2021-11-09 Avenu Medical, Inc. Systems and methods for percutaneous access and formation of arteriovenous fistulas
US10499919B2 (en) 2015-08-21 2019-12-10 Avenu Medical, Inc. Systems and methods for percutaneous access and formation of arteriovenous fistulas
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
US10272230B2 (en) 2015-10-30 2019-04-30 Cerevasc, Llc Systems and methods for treating hydrocephalus
US10307577B2 (en) 2015-10-30 2019-06-04 Cerevasc, Llc Systems and methods for deploying an implant in the vasculature
US10758718B2 (en) 2015-10-30 2020-09-01 CereVasc, Inc. Systems and methods for endovascularly accessing a subarachnoid space
US11684420B2 (en) 2016-05-05 2023-06-27 Eximo Medical Ltd. Apparatus and methods for resecting and/or ablating an undesired tissue
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11207503B2 (en) 2016-11-11 2021-12-28 Avenu Medical, Inc. Systems and methods for percutaneous intravascular access and guidewire placement
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11826504B2 (en) 2017-04-10 2023-11-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US10543308B2 (en) 2017-04-10 2020-01-28 Limflow Gmbh Methods for routing a guidewire from a first vessel and through a second vessel in lower extremity vasculature
US11013900B2 (en) 2018-03-08 2021-05-25 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
US11850390B2 (en) 2018-03-08 2023-12-26 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
US10470797B1 (en) 2018-07-17 2019-11-12 SlipStream, LLC Systems and methods for vascular access
US11389194B2 (en) 2018-07-17 2022-07-19 SlipStream, LLC Systems and methods for vascular access
US11478614B2 (en) 2018-10-09 2022-10-25 Limflow Gmbh Method for accessing pedal veins for deep vein arterialization
US11129965B2 (en) 2018-10-09 2021-09-28 Limflow Gmbh Devices and methods for catheter alignment
US11850379B2 (en) 2018-10-09 2023-12-26 Limflow Gmbh Devices and methods for catheter alignment
US11311700B2 (en) 2018-10-09 2022-04-26 Limflow Gmbh Methods for accessing pedal veins
US11116943B2 (en) 2018-10-09 2021-09-14 Limflow Gmbh Methods for accessing pedal veins
US11612397B2 (en) 2019-11-01 2023-03-28 Limflow Gmbh Devices and methods for increasing blood perfusion to a distal extremity
US11951270B2 (en) 2020-08-05 2024-04-09 Cerevasc, Llc Systems and methods for endovascularly accessing a subarachnoid space
US11950828B2 (en) 2021-10-20 2024-04-09 Avenu Medical, Inc. Intravascular arterial to venous anastomosis and tissue welding catheter

Also Published As

Publication number Publication date
US20030181938A1 (en) 2003-09-25
AU3473799A (en) 1999-10-25
WO1999051162A1 (en) 1999-10-14
AU763400B2 (en) 2003-07-24
EP1069869A1 (en) 2001-01-24
CA2326769A1 (en) 1999-10-14
IL138724A0 (en) 2001-10-31
JP2002510522A (en) 2002-04-09
EP1069869A4 (en) 2006-03-08

Similar Documents

Publication Publication Date Title
US6561998B1 (en) Transluminal devices, systems and methods for enlarging interstitial penetration tracts
US11633207B2 (en) Methods and systems for performing submucosal medical procedures
JP6940575B2 (en) Devices and methods for forming a fistula
US5944716A (en) Radio frequency transmyocardial revascularization corer
AU768035B2 (en) Device for forming holes in tissue
US5738680A (en) Laser device with piercing tip for transmyocardial revascularization procedures
US20050065507A1 (en) Surgical perforation device with curve
US8491613B2 (en) Aortic dissection septal cutting tool
US9387039B2 (en) Aortic dissection septal cutting tool
US20160317174A1 (en) Aortic dissection septal cutting tool
CN114302756A (en) Device for performing interventional endoscopic ultrasound surgery
JPH08509147A (en) Device and method for sealing a vascular puncture
MXPA00009748A (en) Transluminal devices, systems and methods for enlarging interstitial penetration tracts
JP2023175034A (en) Eus access device with electrosurgery-enhanced puncture
WO2023069983A1 (en) Systems and methods for transcatheter surgery

Legal Events

Date Code Title Description
AS Assignment

Owner name: TRANSVASCULAR, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ROTH, ALEX T.;FLAHERTY, J. CHRISTOPHER;JOHNSON, ADRIAN E.;AND OTHERS;REEL/FRAME:009387/0532;SIGNING DATES FROM 19980528 TO 19980629

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: MEDTRONIC VASCULAR, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TRANSVASCULAR, INC.;REEL/FRAME:015000/0001

Effective date: 20030909

FEPP Fee payment procedure

Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

REFU Refund

Free format text: REFUND - SURCHARGE, PETITION TO ACCEPT PYMT AFTER EXP, UNINTENTIONAL (ORIGINAL EVENT CODE: R2551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12